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 The proton-dependent di- and tripeptide transporter P pT1 
represents the major route of dietary amino acid intake in the intestine 
of many species. This transporter belongs to the solute carrier family 
SLC15 and because of its electrogenic properties it may be studied  
both through electrophysiological and radiotracer uptake experiments. 
In this work some functional and structural aspects of PepT1 
have been investigated at the molecular level. In addition to the 
physiological relevance, understanding of the details of its 
mechanisms of operation is important since PepT1 appe rs to be 
involved in the absorption of many important, orally administered, 
drugs such as antibiotics, angiotensin-converting ihibitors, and 
antiviral agents. 
The electrophisyiological and biophysical properties of PepT1 
expressed in Xenopus oocytes were investigated with two-electrode 
voltage-clamp. 
Most of the above functional observations were derived from 
uptake data, in absence of control of the membrane voltage, or from 
electrophysiological measurement of steady transport cur ents, in the 
presence of a dipeptide substrate. Important additional informations 
regarding the transport mechanism may arise from measur ment of 
presteady-state currents, the electrophysiological signals that can be 
observed in absence of organic substrate, and that represent the first 
steps in the transport cycle. A unified kinetic model for PepT1 has 
been devised that can describe the different characteristics of the 
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isoforms of different species, with respect to both presteady-state and 
transport-associated currents. 
Mutational studies have provided significant evidence for the 
functional role of some residues in PepT1. Particularly Arg282 and 
Asp341, in the transmembrane domain 7 and 8 of the transporter, have 
been reported to form a charge pair that may break and reform during 
the transport cycle. The attention has been focused on these two 
oppositely charged aminoacids to better understand heir functional 
role in the absorption pathway.  
Finally, the functional and structural basis of reverse operation 
of wild-type and mutated forms of PepT1 have been studied. Mutants 
in the putative charge pair residues Arg282 and Asp341 of rabbit 
PepT1 have been shown exhibit properties useful to be ter understand 
the possibility of reverse transport. This reversed mode of operation 
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Chapter 1. Introduction 
1.1 Protein digestion and absorption 
Proteins are essential components for nutritional homeostasis 
in humans. Normally, a western diet provides between 70 and 100 g of 
protein/day and, in addition, 50-60 g/day of endogenous proteins are 
secreted along the oro-gastrointestinal tract. These proteins undergo a 
complex series of degradative processes by the hydrolytic enzymes 
secreted from stomach and pancreas or bound to the brush border 
membrane of enterocytes. The result of this proteoly ic activity is a 
mixture of amino acids and small peptides that are rapidly and 
efficiently absorbed by the small intestinal enterocytes (Erickson and 
Kim, 1990;Daniel, 2004). 
Transport across the enterocyte involves uptake from the gut 
across the brush-border membrane, diffusion through the cytoplasm, 
and exit to the portal blood across the basolateral membrane. The 
brush borders contain unique transport properties, while the 
basolateral membranes are very similar to plasma membranes of 
nonepithelial cells (Stevens et al., 1984). Distinct carrier mechanisms 
exist in the brush border membrane for the transport of free amino 
acids and peptides. In fact, not only the free amino acids, but also di- 
and tripeptides are taken up by intestinal epithelial cells in intact form 
by an oligopeptide transporter named PepT1 (Fig.1.1). Following 
apical influx, di- and tripeptides are sequentially h drolyzed by 
multiple cytosolic hydrolases followed by basolaterl efflux of the 
amino acids via different amino acid transporting systems. Peptides 
 
 
not undergoing hydrolysis can exit the cell by a basol teral peptide
transporting system not yet identified on a molecular basis
2004). 
Fig.1.1 Generation and uptake of di
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peptides to enter the cell even against the concentration gradient; 
indeed, the electrogenic PepT1-mediated uptake is independent of 
extracellular Na+, K+ and Cl-, and of membrane potential (Fei et al., 
1994). The H+-peptide cotransport process across apical membranes of 
enterocytes was dimostred in 1980s in earlier studies employing brush 
border membrane vescicles (Ganapathy et al., 1984;Ganapathy et al., 
1985). The acid-loading activity of PepT1 requires the apical Na+/H+ 
antiporter activity which exports protons entering the cell via PepT1 in 
exchange for extracellular Na+ ions (Ganapathy and Leibach, 
1985;Kennedy et al., 2002). 
The controversial discussion about the active transport of short 
chain peptides in the mammalian gut epithelium started in 1960 with 
the discovery of intracellular hydrolysis of dipeptides during intestinal 
absorption (NEWEY and SMYTH, 1960). That oligopeptides were 
able to cross apical membranes was demonstrated by measuring 
hydrolytic activity of peptidases in homogenates of the mucosa and in 
isolated brush border membranes. The almost total activity of 
peptidases with specificity for di- and tripeptides was originated from 
the soluble cytosolic fraction: this suggested that oligopeptides, but 
not tetrapeptides and more longer ones are absorbed in intact form 
(Sterchi and Woodley, 1980;Daniel, 2004). 
After the cloning of the PepT1 cDNA, an important 
demonstration of its relevance in the transfer of intact oligopeptides 
from the gut lumen into blood circulation came from 
pharmacokinetics and cystinuria studies. In this disease the transport 
of amino acids such as arginine and lysine is not sufficient, but 





when they provide this essential amino acid as a lysil-dipeptide and 
not in free form (Hellier et al., 1971;de Sanctis et al., 2001). Finally, 
drugs resistant to hydrolysis, such as aminocephalosporins or ACE-
inhibitors, that utilize PepT1 for intestinal absorption rapidly appear in 
circulation (Fig.1.2). However, the molecular nature of the basolateral 
transport is not known (Daniel, 2004). 
 
 
Fig.1.2 Transport of peptidomimetics (Daniel and Kottra, 2004). 
1.2.2 SLC15 family 
 All the SoLute Carrier (SLC) genes have been classified by the 
Human Genome Organisation (HUGO) in a list of transporter families 
that currently includes almost 50 families and more than 300 
transporter genes. The SLC series includes genes encoding passive 
transporters, ion-coupled transporters and exchangers. The remaining 
transporter-related genes encoding ATP-driven transporters, channels, 






auxiliary/regulatory transport proteins don’t belong to SLC series 
(Hediger et al., 2004). 
PepT1 is the prototype member of the proton oligopeptid  
cotransporter family SLC15 (Fig.1.3). Transporters of the SLC15 
family are electrogenic and utilize the proton-motive force for uphill 
transport of short chain peptides and peptido-mimetics into a variety 
of cells. Four transporters belong to the SLC15 family: the 
oligopeptide transporters, PepT1 and PepT2, and the peptide/histidine 
transporters PHT1 e PHT2. The first two have been ident fied into 
intestinal and renal epithelial cells and more recently into bile duct 
epithelium (PepT1), glia cells and epithelia of thec oroid plexus, lung 
and mammary gland (PepT2). Whereas, it is not yet clear if PHT1 and 
PHT2 are located on the plasma membrane or represent lysosomal 
transporters for the proton-dependent export of histidine and 
dipeptides from lysosomal protein degradation into the cytosol (Daniel 










































































































Tab.1.1 SLC15 family (Daniel and Kottra, 2004). 
 
SLC15 transporters present from 450 to more than 750





eukaryotic ones) and contain 12 transmembrane domains (TMD) with 
the N- and C-termini facing the cytosol. Conserved r sidues are found 
in all family members (Steiner et al., 1995). There is a protein stretch 
located in the end region of the TMD2, the following intracellular 
loop and reaching into TMD3. The second more conserved signature 
motif is found in the central part of TMD5 and comprises a stretch of 
11 amino acid residues (Hauser t al., 2005). Moreover, in the 
mammalian species there is a histidyl residue obligatory for the 
catalytic activity of PepT1 and PepT2 (Fei et al., 1997). 
PepT1 and PepT2 are able to transport all 400 different 
dipeptides and 8000 different tripeptides derived from the 20 
proteinogenic L-α-amino acids; PepT1 represent the low-
affinity/high-capacity variant, and PepT2 the highaffinity/low-
capacity variant. PHT1 and PHT2 accept also free histidine as a 
substrate, but it is not known if they can transport the same spectrum 
of di- and tripeptides of PepT1 and PepT2. The peptid /histidine 
transporters appear to be phylogenetically similar to proton 
oligopeptide transporters found in plants, which mediate the transport 
of histidine, nitrates, di- and tripeptides. The mammalian SLC15 
members can only transport di- and tripeptides, whereas in bacteria, 
yeast and plants there are proton oligopeptide cotransporter with the 
capability of transporting peptides containing more than three amino 







1.2.3 PepT1 gene 
 In 1994, the complementary DNA coding for rabbit PepT1 was 
cloned screening an intestinal cDNA library by uptake of glycyl-
sarcosine 14C-labelled in Xenopus laevis oocytes (Fei et al., 1994). 
Subsequently, PepT1 was isolated by expression and ge omic cloning 
from other species such as human (Liang et al., 1995), rat (Saito et al., 
1995), Caenorhabditis elegans (Fei et al., 1998), mouse (Fei et al., 
2000), sheep, cow, pig, chicken (Chen et al., 1999;Chen et al., 2002), 
zebrafish (Verri et al., 2003) and macaco (Zhang et al., 2004). 
The gene encoding hPepT1 maps to human chromosome 
13q33–34 (Liang et al., 1995) and consists of 23 exons. The open 
reading frame encodes 708 amino acids and the sequence presents 
50% identity and 70% similarity to PepT2. In general, mammalian 
PepT1 genes present a high degree of similarity in both clustering and 
coding sequences. In particular, it is thought thatPepT1 orthologues 
genes evolved by exon shuffling and rearrangements of functional 
modules, because the genomic structures of human and mouse PepT1 
genes are modular, with each transmembrane segment and loop unit 
encoded by a different exon (Fig.1.3). The putative promoter region of 
hPepT1 contains TATA boxes and GC-rich regions. TATA boxes are 
located in unusual positions (511 bp and 517 bp upstream from the 
transcription start site), while GC boxes are located near the start site 
(at -29 bp and several others within 300 bp). This kind of structure 
suggests that the GC box is a more important promoter in the 
regulation of hPepT1 than is the TATA box. However, there may also 
be more than one transcription start site. There is also a potential 





start site: this suggests that insulin might be involved in the regulation 
of hPepT1 transcriptional activity (Urtti et al., 2001). 
 
Fig.1.3 Gene and cDNA organization of mouse PepT1 (Fei et al., 2000). 
1.2.4 PepT1 structure: from the prediction to the 
crystal 
Rabbit PepT1 is a protein of 707 amino acids organized nto 12 
membrane-spanning regions and a big loop between TMD9 and 
TMD10 with the N- an C-termini facing the cytosol (Fig.1.4). The 
molecular weight is 71 kD of which at least 11 kD are due to N-linked 
glycosylation: the putative N-glycosylation sites are Asn 50, 439, 498 
and 513. There are also a protein kinase C site (PKC, Ser 357) and a 







Fig.1.4 Membrane topology of rabbit PepT1 (Fei et al., 1994). 
 
The membrane topology of PepT1 has been proposed from the 
first cloning from rabbit small intestine: the classical hydropathy plot 
suggested that rbPepT1 has 12 TMD (Fei et al., 1994). This model 
was tested and confirmed in hPepT1 (81% identity with rbPepT1) by 
inserting epitope tags into predicted intra- or extracellular loops, and 
determining their accessibility to an anti-epitope antibody (Covitz et 
al., 1998). More recently, other information about themode in which 
the TMDs might be arranged in the membrane are derived from site-
directed mutagenesis of individual residues (Meredith, 2004), cysteine 
scanning of TMDs (Kulkarni et al., 2003a;Kulkarni et al., 2003b) and 
from indirect computer-based approaches. The original 12 TMDs 
model has been refined by using the program MEMSAT (MEMbrane 





the exact residues forming TMDs 1 and 2 (McGuffin et al., 2000) and 
the program Cn3D correlating the rbPepT1 sequence with those of the 
previously crystallized bacterial transporters LacY (E.coli proton-
coupled lactose permease, (Abramson et al., 2003) and GlpT 
(glycerol-3-phosphate/inorganic phosphate antiporter, (Huang et al., 
2003;Meredith and Price, 2006). Moreover, there are evidences that 
PepT1 acts as a multimer: according to the suggested modeling PepT1 
could be a tetramer, with a minimum requirement of wo functional 
subunits in each protein complex (Panitsas et al., 2006). 
Finally, in the end of 2010, the crystal structure of a peptide 
transporter from the bacterium Shewanella oneidensis, PepTSo, has 
been reported by Newstead and coworkers (Newstead et al., 2011). 
This bacterial homologue shows 30% identity within the TM regions 
to the mammalian PepT1 and PepT2 proteins and kinetic properties 
very similar to those reported for hPepT1. All previously identified 
residues proposed to be functionally important in the mammalian 
transporters are conserved (Newstead t al., 2011). The overall fold 
adopted by TM helices is the same observed for the 12 TMDs in 
LacY, GlpT and EmrD (E.coli multidrug transporter) (Abramson et 
al., 2003;Huang et al., 2003;Yin et al., 2006). But PepTSo contains 14 
TMD: helices H1–H6 and H7–H12 form six-helix bundles that come 
together to form a ‘V’-shaped transporter, related by a pseudo two-
fold symmetry axis running perpendicular to the membrane plane. The 
two additional TM helices, HA and HB, are inserted into the 
cytoplasmic loop forming a hairpinlike structure to c nnect the N- and 





conserved transport mechanism because are absent in all other species 
(Newstead et al., 2011). 
 
Fig.1.5 Structure of PepTSo. A: PepTSo topology. B: View in the plane of the 
membrane. C: View from the extracellular side of the membrane 
(Newstead et al., 2011). 
 
 In the crystal structure there are two hydrophilic cavities, one 
central and one smaller extracellular (Fig.1.5 B). The central cavity is 
in the centre of the membrane closed to the extracellular space by a 
gate formed by helices H1, H2, H7 and H8. Access to the cytoplasm 
from this cavity is restricted by an intracellular gate formed by side-
chain interactions between two-helix hairpins, helices H4 and H5 on 
the N-terminal side, and H10 and H11 on the opposing C-terminal 
side (Fig.1.5 C) (Newstead et al., 2011). The interaction between 





vertebrate peptide transporters; the most prominent of these 
interactions involves part of the highly conserved PTR2 (Peptide 
Transport family) motif (FYxxINxG) in which point mutations 
inactivate or greatly impair the transport (Hauser et al., 2005). 
The smaller extracellular cavity is also located at the interface 
between the N- and C-terminal domains. It is cone shaped, with the 
apex at the bottom near the central cavity, opening outward and its 
overall dimensions are ~16 x 8 x 8 Å. This cavity can represent the 
vestiges of entrance for peptides because is similar to the one 
representing the exit pathway for substrate in EmrD (Newstead et al., 
2011). 
1.2.5 The oligopeptide-binding site 
 Waiting for the crystal structure, different groups using 
computer modeling methods predicted an arrangement of the 12 
TMDs to form a transmembrane channel (Bolger et al., 1998;Yeung et 
al., 1998). This model of hPepT1, based on the amphipathicity of the 
helices and on minimizing interactions of the faces of TMDs in 
pairwise fashion, was refined by Lee and coworkers. The 
transmembrane channel is described like a “bubble”, a vestibule large 
enough to accommodate a dipeptide (Lee et al., 1999). Some years 
later, Meredith by modeling rat PepT1 on the LacY crystal structure 
reviewed the position of the TMDs (Fig.1.6 A). This model corrected 
Lee’s group assumptions that TMDs adjacent in the sequence are also 
physically adjacent in the membrane and that the helices cross the 
lipid bilayer perpendicular to the surface. The helical wheels were 





predicted to have a role in the substrate binding (Fi .1.6 B) (Meredith 
and Price, 2006). 
 
Fig.1.6 A: 12-TM model for hPepT1. B: Schematic representation of the 
transmembrane channel with vestibule (‘bubble’) 
(Meredith and Price, 2006). 
 
 After the crystallization of PepTSo (Newstead et al., 2011), it is 
believed that the central hydrophilic cavity observed in crystal could 
represent the oligopeptide-binding site because its dimensions, ~ 13 x 
12 x 11 Å, are sufficient to accommodate both di- and tri-peptides. 
Moreover, these dimensions are sterically restrictive for larger tetra-
peptide ligands and can also explain the lack of affinity for single 
amino acids that cannot interact sufficiently with both the N- and C-
terminal domains of the transporter. 
The binding site (Fig.1.7) is formed by residues from helices H1, 
H2, H4 and H5 from the N-terminal six-helix bundle and from helices 
H7, H8, H10 and H11 from the C-terminal bundle. On the N-terminal 
side there is a positively charged cluster of three conserved residues, 
Arg25(27), Arg32(34) and Lys127(140) (numbers in brackets 





conserved tyrosine residues, Tyr29(31) and Tyr68(64), are positioned 
close to this. On the C-terminal side, at a distance of ~ 13 Å from 
Lys127(140), are two further strictly conserved residues, Glu419(595) 
and Ser423(599), located in close proximity to Tyr154(167). The 
presence of a negatively charged residue at this position is important 
because the arrangement of opposite charges within the binding site 
could be a role in the recognition and orientation of peptides through 
the creation of a dipole moment. The presence of several possible 
hydrogen-bond donors and acceptors, as the tyrosine residues, could 
be advantageous in adapting to peptides of various lengths, sequences 
and charges (Newstead et al., 2011). 
 
Fig.1.7 The Peptide-binding site of PepTSo (Newstead et al., 2011). 
 
Water also plays a key role in the docking process indeed both the 
two cavities observed in the crystallized PepTSo are fully solvated. 
Water acts as a versatile space filling buffer betwe n the substrate and 
the carrier-binding site and both charged and polar, as well as large 





1996). But most of the conserved residues in the binding site are 
hydrophobic residues, including Ile157(170), Trp312(294), 
Phe315(297) and Trp446(622). These hydrophobic pockets, predicted 
also by biochemical studies, are likely to provide a suitable 
environment for peptide side chains generally (Bailey et al., 2000) 
more hydrophobic than the peptide backbone. In fact, mutation of 
Trp312(294) of PepT1 to alanine reduces substrate uptake in HEK293 
cells (Bolger et al., 1998). Interestingly, some conserved residues are 
not located in the peptide-binding site but close to the central cavity 
and may have an important role in positioning residues involved in the 
substrate-binding (Newstead et al., 2011). 
Detailed structural information about the substrate binding site are 
important not only to understand the mode of transport by which 
PepT1 binds and transports its substrates that it’s of great interest to 
researchers, but also to make PepT1 a good drug delivery system. 
1.2.6 Substrate specificity 
All information about the substrate specificity of PepT1 derive 
from detailed studies in which an enormous number of di- and 
tripeptides, amino acid derivatives and inhibitors have been tested by 
electrophysiological techniques, competition assays and also 
computational modeling. This large analysis has provided a good 
prediction of the substrate-binding template before than the binding 
site features were published with the crystal structure of a prokaryotic 
homologue of PepT1 (Newstead et al., 2011). 
PepT1 can transport thousands of di- and tripeptides that differ 





even the mesomeric structure of the peptide bond. It’s hard to imagine 
that a single carrier protein would be able to transport these quite 
different substrates. For example, the molecular mass can vary 
between 132 Da for a di-glycine and 577 Da for a tri-tryptophane, and 
the net charge can range (at pH 7) from neutral to trivalently anionic, 
as for a triglutamate, or trivalently cationic, as for a tri-lysine. But 
evidences of multiple peptide transporters for the different substrate 
groups, initially postulated in the brush border membrane of intestinal 
epithelial cells, have not yet provided (Daniel, 2004). 
 The most simple substrate structures transported by PEPT1 are 
omega-amino fatty acids. This demonstrates that minimal molecular 
determinants of substrates for recognition by the transporter are two 
oppositely charged head groups (i.e., amino and carboxy groups) 
separated by at least four methylene groups (Fig.1.8). The distance of 
5.5 to 6.3 Å between the centers of the head groups ex lains why 
neither free amino acids nor tetrapeptides can be bound or transported 
(Doring et al., 1998b). 
All additional structural features in a compound eith r modulate 
substrate affinity or even prevent substrate binding, i deed the peptide 
bond is not a prerequisite for substrate recognition. When an 
additional carbonyl group is incorporated into the backbone, as 
realized in delta-aminolevulinic acid (ALA), substrate affinity of the 
amino fatty acid increases. The carbonyl oxygen in the peptide bond is 
the relevant functional component because it can form additional 
hydrogen bonds with the substrate-binding domain. Whereas, if the 
peptide bond is replaced by an isosteric thioxo bond r if the peptide-





(Doring et al., 1998a). Moreover, the α-amino group of the peptide 
transporter substrates and its spatial location play a crucial role in 
binding affinity and translocation. This group may form a salt bridge 
with either an acidic residue or a histidine residue located in the 
substrate binding pocket. In fact, peptides containing proline residues 
are critical substrates not only with respect to the conformation of the 
peptide bond but also with respect to other structual constraints. 
When provided in an aminoterminal position in peptides, the α-amino 
group is embedded into the pyrrolidine ring system: the peptide bond 
has a rigid, planar double-bond structure and the carbonyl-oxygen that 
generally increases the affinity of substrates, becomes negatively 
charged impairing interaction with the transporter. The consequence is 
a marked reduction in substrate affinity (Brandsch et al., 1998). 
However, there are substrates in which the α-amino group is not 
present, such as in some ß-lactams and ACE-inhibitors hat are 
transported by PepT1. Therefore, other groups in these compounds 
could interact with different residues in the binding domain (Daniel, 
2004). The transporter can accommodate such a largenumber of 
different structures because water shields electric harges of amino 
acid side chains in the carrier’s substrate-binding domain weakening 
unfavorable interactions between charged substrate groups and the 
protein (Tame et al., 1996). Moreover, the substrate binding site of 
PepT1 is strongly stereoselective and oligopeptides containing solely 
D-enantiomers of amino acids are not transported. However, PepT1 is 
able to transport peptides containing both L- and D-amino acid 
residues: in this case the affinity depends from the D-enantiomers 





the amino-terminal ocation, whereas when located in the carboxy-
terminal position of a peptide, affinity is markedly reduced (Daniel, 
2004). 
 
Fig.1.8 Molecular determinants of PepT1 substrates 
(Daniel and Kottra, 2004). 
1.2.7 Critical residues in PepT1 
Significant evidences about the critical role of some residues in 
PepT1 derive from mutational studies. Histidine 57 (H57) in the 
second transmembrane domain (TM2) is essential for PepT1 function 
(Fei et al., 1997;Chen et al., 2000;Uchiyama et al., 2003) and the 
protonation of this residue is a necessary step in the transport cycle 
(Steel et al., 1997). In fact, when protonated, H57 has been proposed 
to bind the carboxy terminus of the peptide substrate (Terada et al., 
1996;Bailey et al., 2000). The neighboring tyrosine, Y56, has also 





Y167, to play important roles in determining the affinity and transport 
rate of rabbit PepT1 forming hydrogen bonds and providing a 
hydrophobic environment for side chains (Uchiyama et l., 2003;Pieri 
et al., 2009). In addition, histidine 121 (H121) in TM4 has a 
functional role in the central cavity of PepT1 (Terada et al., 1996) and 
also three residues of TM7, F293, L296 and F297, subjected to 
cysteine-scanning mutation analysis, are structurally important for 
PepT1, because of their hydrophobic packing interacion (Kulkarni et 
al., 2003b). Again a structural role was proposed for tryptofane 294 
(W294), because some PepT1 mutants in this residue don’t have any 
detectable transport activity, even if W294 was tolerant of cysteine 
replacement in human PepT1 (Bolger t al., 1998;Panitsas et al., 
2006). Various mutants of glutamate 595 (E595) in PepT1 have been 
reported to drastically reduce transport activity, except where 
mutation was to an aspartic acid (Xu et al., 2009), indicating the 
importance of a negatively charged residue at this po ition. In fact, 
E595 could bind the amino termini of PepT1 substrates, since together 
with H57 forms a dipole moment important in the recognition and in 
the arrangement of peptides (Bailey t al., 2000). Other residues have 
been found to affect PepT1 activity in interesting ways: particularly 
Arg282 (R282) and Asp 341 (D341) have been reported to form a 
charge pair that may break and reform during the transport cycle 
(Kulkarni et al., 2007;Pieri et al., 2008;Meredith, 2009). Interestingly 
mutation R282E appeared to convert the cotransporter in a substrate-






1.3 Electrophysiological properties of PepT1 
Overexpression of ion-coupled cotransporters in heterologous 
systems, especially Xenopus laevis oocytes, allows precise 
electrophysiological measurements which reveal detailed features in 
the kinetic mechanism. 
PepT1 as well as most cotransporters displays two main kinds 
of electrical activity: in the absence of organic sub trate, transient 
presteady-state currents (Ipre) are generated by charge relocation 
during voltage steps; in the presence of substrate, transport-associated 
currents (Itr) are recorded. 
1.3.1 Presteady-state currents and transport-
associated currents 
Ipre has the characteristics of an intramembrane charge 
movement, as it is transient, saturable and symmetric (Mager et al., 
1993;Bossi et al., 1999;Forlani et al., 2001). Conversely, Itr is true 
transmembrane current, as the actual charge carriers physically move 
from the extracellular to the cytosolic compartment or vice versa. Ipre 
and Itr are reminiscent of two distinct currents in voltage-dependent 
ionic channels: the gating current and ionic current through the 
channel itself, respectively (Armstrong and Bezanill , 1974;Hille, 
2001). In ionic channels clearly distinct functions have been assigned 
to the two currents. The gating currents are believd to signal the 
conformational changes that accompany opening (or closing) of the 
permeation pathway (Catterall, 1993). The current through the channel 
can only occur when the gates are open, and therefor  a simple 





channel being open and the current flux. Whereas the ionic current 
obviously depends on the presence and on the equilibri m potential of 
the permeating ion and this parameter does not affect the gating 
currents (Fesce t al., 2002). 
In cotransporters the situation is certainly less clear, in fact, the 
charges responsible for Ipre cannot be clearly distinguished from those 
giving rise to the transmembrane current flux. Ipre of cotransporter 
may also be explained as due to rearrangement of a charged portion of 
the protein in the membrane field (Mager t al., 1996;Loo et al., 
1998); however, the charge relocation might be due to the motion of 
ions that move back and forth between the external solution and an 
open vestibule in the transporter facing the extracellular side (Mager 
et al., 1996;Lester et al., 1996). Whatever the actual mechanism, it is 
generally agreed that presteady-state currents repres nt a partial step 
in the transport cycle. The time integral of this kind of current 
represents the amount of charges that moves in the membrane 
electrical field in response to the voltage change. It is possible to note 
that the same amount of charges moves during the “on” (from the 
holding potential, Vh, to a given potential) and the “off” (when the 
voltage is returned back to Vh) of the voltage pulse (Fig.1.9 B). Such 
behavior is reproduced by a simple electrical circuit onstituted by a 
resistor and a capacitor in series (Fig.1.9 A): here a voltage step ∆V 
generates a current given by: 
 =  exp 
−

,            [eq.1.1] 
which declines to zero with a time constant given by τ = RC 
and displaces an amount of charge Q = C∆V onto the capacitor plates 






Fig.1.9 A: Electrical circuit simulating intramembrane charge movement. 
B: time course of the relevant electrical quantities n response to step 
voltage changes across the membrane (Peres et al., 2004). 
1.3.2 Intramembrane charge movement 
The empirical relations explaining electrophysiological 
observations represent the starting point for the development of 
kinetic schemes of heterologously espressed transporters. In the 
simplest formalization a two-state system is assumed: in state A the 
electrical charge associated with the transporter is located near the 
internal limit of the membrane electrical field, while in state B the 
charge is displaced toward the outer membrane margin (Fig.1.10). 






membrane potential: assuming a positive mobile charge, state A in 
Fig.1.10 will be populated at negative internal potentials, while at 
positive potentials the most populated state will be B. This description 
may be translated in terms of reaction kinetics described in the figure: 
 
Fig.1.10 Elementary representation of a two-state system explaining 
intramembrane charge movement. 
 
in which α and β are the voltage-dependent unidirectional rate 
constants (dimensions s-1) for the outward and inward charge 
movement, respectively.  
Consistent with the laws of electrodiffusion, α and β will depend 
on the membrane voltage according to the following general kind of 
expressions: 
α = kα exp(qδV / 2kT ) 
            [eqs 1.2] 
β = kβ exp(- qδV / 2kT ) 
where q is the elementary charge, δ is the fraction of electrical 
field over which the charge movement occurs, k is Boltzmann’s 
constant, T the absolute temperature and kα and kβ are the zero voltage 
rate constants. Clearly, α will increase as the membrane potential is 
made more positive and β will increase as the membrane potential is 







Considering a given population of molecules that can undergo 
reaction in Fig.1.10,  +  = constant, and defining the relative 
amounts of A and B as: 
∗ =      and     




∗ + ∗ 
    [eqs 1.4] 

 = 
∗ − ∗ 
it is easy to verify that at equilibrium, B* is given by: 
∗ =  ( + )⁄              [eq.1.5] 






           [eq.1.6] 
which is a Boltzmann relation with slope s = qδ/kT , and in which 
the molecules are equidistributed in the two states  voltage  * +⁄ =
ln (.//.0)/s. 
From eqs 1.4 it is also easy to derive the differential equation that 
describes the approach to equilibrium following a voltage jump: 
1∗
1 =   − ( + )
∗                [eq.1.7] 
which may be solved to give: 
 ∗ = 2∗ + (3∗ − 2∗)(1-exp[-t/τ])               [eq.1.8] 
where the subscript 0 and ∞ respectively refer to the value before 
and after the voltage jump, so that 2∗ and 3∗  are the fractions of 
molecules in state B before and after the voltage change respectively; 
they may be obtained from eq.1.5 by using the corresponding values 














The time constant of the exponential is: 
τ = 1/(3 + 3)           [eq.1.10] 
Calling Qmax the total amount of electrical charge involved in the
process, the time course of the transient current elicited by voltage 
changes can be obtained by differentiating eq.1.8 and multiplying the 
result by Qmax, which gives: 
 = :;<=(>
∗ $?∗)
@ exp (−/τ)             [eq.1.11] 
This expression constitutes the basis for the analysis of the presteady-
state currents observed in transporters. Fitting eq.1.11 to the 
experimental traces of transient current yields the time constant of 
decay, τ, while the time integral gives: 
A  = BCDE(3∗ − 2∗)
3
2               [eq.1.12] 
which represents the amount of charge moved by the voltage 
jump. 
In particular, at any membrane voltage the quantity of charge 
displaced towards the inner side is given by BFG(*) = BCDE∗ =
BCDE /0/. If, in agreement with standard notation, a minus sign is 
assigned to inward charge movement, this may be rewritt n as: 
B(*) = −BCDE /0/. 
The analysis of presteady-state currents is performed by first of all 
isolating these currents from the endogenous components of the 





achieved by subtracting the traces recorded in conditi s in which the 
presteady-state currents have been eliminated, by the use, for instance, 
of saturant concentration of substrate (Fig.1.11B), from the 
corresponding traces recorded in control conditions  (Fig.1.11A) 
(Bossi et al., 1999). A correction of the baseline may consequently be 
necessary before performing the integration of the transients 
(Fig.1.11C). The graph of the integrated charge against voltage shows 
the typical sigmoidal shape (Fig.1.11E) expected from eq.1.6. For 
each voltage step the “on” and “off” integrals coincide, as expected in 
a process in which the fraction of charge in the two positions at 
equilibrium conditions is determined only by voltage. 
The relaxation time constant τ may be obtained by fitting single or 
multiple exponentials to the current records at each potential; a 
representative τ vs. V plot is shown in Fig.1.11D. The τ vs. V plot is 
bell-shaped, confirming the expectations of equations 1.2 and 1.10. 
Furthermore, the theory outlined above predicts that e maximum 
value of τ should occur at the voltage where 50% of the charge is in 
one position and 50% in the other and τ should depend only on the 








Fig.1.11 Analysis of presteady-state currents for the oligopeptide 
transporter rbPepT1. A: traces recorded in physiogical solution, containing 
98 mM Na+ among other ions; B: traces from the same oocyte after dding 3 
mM Gly-Gln; C: isolated presteady-state currents reulting by the 
subtraction of the traces in B from those in A. D: relaxation time constant of 
the transient currents in C as function of voltage; E: charge vs. V plot from 
the integration of the transient currents. 
1.3.3 Transport mechanism of PepT1 
In 1996, Wright and coworkers have investigated the transport 
mechanism of human intestinal PepT1 with regard to voltage 
dependence, steady-state kinetics and transient charge movements 
using two microelectrode voltage clamp in Xenopus oocytes 
expressing the transporter. They found that H+/Gly-Sar cotransport 
obey Michaelis-Menten-type kinetics. The apparent affinity constant 
for Gly-Sar is ~ 0.7 mM at Vm -50 mV (in the pH range 5.0–6.0). At 
each Vm, Hill coefficients are ~1 for H
+ activation of the Gly-Sar-
evoked current, suggesting 1 H+:1 Gly-Sar transport stoichiometry. In 































the presence of H+, but in the absence of Gly-Sar, they observed 
voltage-dependent presteady-state currents. According to their model 
(Fig.1.12), these transient currents are due to binding/dissociation of 
H+ to/from the cotransporter and a conformational change of the 
unloaded carrier between the external and internal membrane 
interfaces. Presteady-state data indicate that H+ can bind to the empty 
carrier in the absence of oligopeptide. The steady-state data indicate 
that H+ and oligopeptide are translocated simultaneously in the same 
reaction step, because, at least at Vm more positive than -70 mV, the 
affinity of the carrier for substrate (Gly-Sar) deteriorates at 
diminishing [H+]o. Moreover, the transporter prefers to bind H
+ and 
substrate in an orderly fashion, H+ first. In fact, the apparent maximal 
transport rate is significantly attenuated only once [H+]o was reduced 
100-fold, and even then the reduction in Imax is less than for a system 
in which activator and substrate binding was random (Mackenzie et 
al., 1996). 
 
Fig.1.12 Model of charge movement proposed by Wright and coworkers for 





One year after, a more detailed transport mechanism 
considering the affect of intracellular pH on the pre-steady-state 
kinetics of rabbit PepT1 was purposed (Nussberger et al., 1997). 
 
Fig.1.13 Model of charge movement proposed by Hediger and coworkers for 
rabbit PepT1 (Nussberger et al., 1997). 
 
According to this revised model (Fig.1.13) the empty carrier has a 
single H+-binding site that is symmetrically accessible from both sides 
of the membrane. H+ binding to the extra- or intracellular surface is 
followed by a conformational change resulting in the formation of 
outwardly or inwardly facing occluded states, respectiv ly, and that 
these protonated states cannot cycle between the inside or outside in 
the absence of peptide. The pre-steady-state currents in response to 
voltage jumps are due to binding or dissociation of H+ within the 
membrane electric field near the extra- or intracellular transporter 
surface (steps 2/1 and 4/5) and to reorientation of the empty carrier 
during the voltage sensitive conformational change (step 6). 
Increasing the H+ chemical gradient and/or decreasing Vm 






state. In other words, acidic pH increases the number of PepT1 
molecules in the outwardly facing state that has an increased affinity 
for peptides. Similarly, decreasing the H+ chemical gradient and/or 
increasing Vm (depolarization) shift the carrier toward the inwardly 
occluded state. 
Thus, the model predicts that the magnitude and polarity of the 
transient charge movements depend on the H+ electrochemical 
gradient. According to the authors, from a physiological persctive, 
this concept makes sense because the pH near the intestinal brush 
border membrane is acidic (pH 5.5–6.0), which favors the outwardly 
occluded state and promotes efficient peptide absorption (Nussberger 
et al., 1997). 
New implications for proton-driven peptide symport derive 
from crystal structure of PepT1. 
 
Fig.1.14 Mechanism for peptide–proton symport proposed for PepTSo 





The PepTSo structure presents a ligand-bound occluded 
conformation with a clearly identified substrate-binding site. Both 
ends of the central cavity containing residues involved in peptide 
binding are closed. For uptake of peptide, the central cavity needs to 
be connected to the extracellular space, potentially through the 
extracellular cavity (Fig.1.14). The central and extracellular cavities 
are separated by a putative extracellular gate, which is made of helix 
H7. Opening of the intracellular gate seems to be controlled by the 
movement of helix hairpin H10–H11 in the C-terminal helix bundle. 
This hairpin, forming a restriction for exit of bound peptide to the 
intracellular side, would move together with the subb ndle C1, 
composed of helices H7, H11 and H12. From this structu al model 
employed to explain PepT1 transport, the N-terminal helix bundle 
seems less dynamic, whereas the C-terminal helix bundle contains the 
mobile gates, quite possibly driven by the proton electrochemical 
gradient. To understand the mechanism in full however, it will be 
essential to determine the PepTSo structure in different conformational 
states and determine the sites of protonation and peptide binding 
(Newstead et al., 2011). 
1.3.4 Mode of transport 
How does PepT1 successfully link the transport of such 
diverse compounds to the cotransport of protons? In 1997, Hediger 
and coworkers published a study in which they examine the 
stoichiometry of neutral and charged dipeptides transported by rabbit 
PepT1 expressed in Xenopus oocytes and the pH dependence of the 





uptake of extracellular Na+, K+ and Cl- is confirmed (Fei et al., 1994) 
and, moreover, it was demonstrated that peptide-evoked fluxes are 
entirely due to H+ movement since the transporter doesn’t display 
substrate-gated anion conductances. Using a set of substrates, kinetic 
parameters and transport efficiency are determinated for various 
classes of dipeptides. Neutral, acidic as well as basic dipeptides 
induce intracellular acidification. Maximal transport f Gly-Leu, Gly-
Glu, Gly-Lys and Ala-Lys occur at pH 5.5, 5.2, 6.2 and 5.8, 
respectively. The Imax values are relatively pH independent but the 
apparent affinity (Km) values for these peptides are highly pH 
dependent. In other words, at physiological pH (pH 5.5-6.0) PepT1 
prefers neutral and acidic peptides. 
The rate of intracellular acidification (measured using a pH-
sensitive microelectrode), the initial rates of the uptake of 
radiolabelled peptides and the associated charge flux s gave proton-
substrate coupling ratios of 1:1, 2:1 and 1:1 for neutral, acidic and 
basic dipeptides, respectively. In particular, according to the purposed 
model for the coupled transport (Fig.1.15), negatively charged 
dipeptides are cotransported with two protons, one f which is 
involved in H+ coupling while the other is predicted to neutralize the 
charge on the substrate creating a zwitterionic species. On the other 
hand, a single proton is cotransported with positively charged 
dipeptides and the transport optima is shifted towards more basic pH 
values. To account for this, a histidine residue located near the peptide 
site is predicted to be deprotonated at or above pH 6.0 to allow 







Fig.1.15 Model for coupled transport of neutral and charged dipeptides by 
PepT1 (Steel et al., 1997). 
1.4 Regulation, pathological implications 
and pharmacology of PepT1 
1.4.1 Regulation of PepT1 transport activity 
 PepT1 activity is modulated by regulation factors acting on the 
gene expression or influencing the targeting of the transporter on the 
membrane. 
Intracellular signaling pathways induce acute changes in the 
transport activity. An activation of PKC stimulates endocitotic 
mechanisms causing a rapid decline in apical peptid uptake based on 
a decreased Vmax without changes in substrate affinity. 
Prolonged exposure to substrates also causes PepT1 r trieval 
from the membrane via endocytosis without to involve PKC pathways 
(Mertl et al., 2008). In contrast with these observations, conducted on 
rabbit PepT1 expressed in Xenopus oocytes, long-term incubation of 
human intestinal Caco-2 cells in a dipeptide-containing culture 
medium increases the Vmax of hPepT1 with no change in Km 
(Thamotharan et al., 1998). 
These apparently opposite findings can be explained by the 





increase de novo synthesis of new carrier proteins; since the oocyte 
does not express endogenously oligopeptide transporters, and it cannot 
respond like a mammalian cell with alterations in gene transcription, 
the type of adaptation observed in Caco-2 cells cannot be expected in 
oocytes (Mertl et al., 2008). 
Other regulation pathways involve cAMP; increasing 
intracellular cAMP levels by cholera toxin or forskolin treatment 
inhibits peptide transport (Muller et al., 1996), whereas a decrease in 
the cAMP-level, for example, by the adrenoreceptor agonist clonidine, 
stimulates transport as shown in Caco2–3B cells andin the rat 
jejunum (Berlioz et al., 1999;Berlioz et al., 2000). 
An acute effect on the transport activity of PepT1 is observed by 
alterations in intracellular free calcium concentration. An increase in 
free calcium rapidly decreases activity, whereas a decrease in free 
calcium causes an increased Vmax of PepT1 (Wenzel et al., 2002).  
PepT1 transport activity also depends on the transmembrane 
proton gradient, which is mainly generated by the apical Na+/H+ 
exchanger and any alterations of pH gradients and membrane potential 
secondarily affect PepT1 activity (Thwaites t al., 2002). 
Indeed, a pH-sensing regulatory factor of hPepT1 (hPepT1-RF) 
was cloned and characterized; its amino acids sequence is more 
shorter but almost the same than PepT1: residues 18–195 in hPepT1-
RF are identical to residues 8–185 in hPepT1, whereas r sidues 1–17 
and 196–208 are unique. When expressed in Xenopus oocytes, 
hPepT1-RF alone does not induce any peptide transport activity, but 





inactivated at lower pH than in presence of PepT1 alone (Saito et al., 
1997). 
A regulation of PepT1 abundance and activity in epithel al 
cells can be observed by hormones such as insulin, leptin, growth 
hormone, and thyroid hormone (Thamotharan et al., 1999b;Buyse et 
al., 2001;Ashida et al., 2002). Insulin stimulates dipeptide uptake into 
Caco-2 cells increasing the Vmax without changes in Km (Thamotharan 
et al., 1999b). Similarly, leptin was shown to enhance dipeptide 
uptake into Caco-2 cells and in the rat intestine (Buyse et al., 2001). 
Whereas both hormones appear to increase the PepT1 protein density 
in the apical membrane by recruitment of preformed transporters, 
without changes at the transcriptional level, treatment of Caco-2 cells 
with 3,5,3’-triiodothyronine (T3) reduces the Vmax for dipeptide influx 
significantly with a concomitant reduction in the PpT1 mRNA to 
30% of control level (Ashida et al., 2002). Recombinant human 
growth hormone has recently been shown to increase peptide transport 
activity in Caco-2 cells (Sun et al., 2003) and in combination with 
epidermal growth factor also increased PepT1 expression in the rabbit 
small intestine after midgut resection (Avissar et al., 2001). 
Several studies have demonstrated that the expression level of 
PepT1 and its function is altered by dietary treatments. In rats, a brief 
fast (Thamotharan et al., 1999a), as well as sustained starvation and 
malnourishment (Ihara et al., 2000), is associated with a high 
expression level of PepT1. This is important also with respect to 
protein assimilation in states of impaired jejunal structure and 
function, suggesting that the high resistance of the intestinal 





increased protein synthesis rate (Tanaka et l., 1998). Moreover, free 
amino acids and dipeptide, especially Phe and Gly-Phe, increase 
PepT1 expression by a mechanism involving transcription factors 
associated with gene regulation under essential amino acids 
deprivation (Pohjanpelto and Holtta, 1990;Guerrini et al., 1993). 
Recently, a microRNA-mediated regulation of PepT1 
expression was observed during the differentiation of intestinal 
epithelial Caco-2 cells. It was demonstrated that microRNA-92b 
(miR-92b) suppresses PepT1 expression, by directly targeting the 
PepT1 3’-untranslated region, at both mRNA and protein levels, with 
subsequent reduced PepT1 transport activity. In addition, miR-92b 
suppresses bacterial peptide-induced proinflammatory responses in 
intestinal epithelial cells by inhibiting PepT1 expression (Dalmasso et 
al., 2011). 
PepT1 activity shows also a circadian rhythm: substrate 
transport and mRNA expression of intestinal rat PepT1 are greater in 
the dark phase than the light phase. In contrast, renal isoform of the 
transporter shows little diurnal rhythmicity in protein and mRNA 
expression. These findings indicate that PepT1 regulation could affect 
the intestinal absorption of dietary protein (Pan et al., 2002). 
1.4.2 PepT1 implications in pathological states 
Several studies have demonstrated PepT1 implications in 
pathological states that alter the expression level and the function of 
the transporter. 
Diabetes, for example, induces an increased protein expression 





treatment with streptozotocin, the maximal peptide ransport activity 
increases almost twofold than in the control. In particular, diabetes 
increases the abundance of mRNA encoding PepT1 without altering 
its rate of transcription, but increasing in the stabilization of mRNA 
encoding the transporter. Lastly, studies show that di betes similarly 
affects the protein and gene expression of the renal isoform of the 
transporter (Gangopadhyay et al., 2002). 
Bacterial infections have also been demonstrated to al er 
PepT1 expression level and function in the gut. For example, in rats 
infected with Cryptosporidium parvum, which causes diarrhea in 
children and may lead to malnutrition, PepT1 is up-regulated at 
transcriptional level (Barbot et al., 2003). It was reported that 
pathogenic bacteria induce PepT1 expression in colonocytes via the 
transcription factor Cdx2 (Nguyen et al., 2010). 
PepT1 is expressed throughout the small intestine and is absent 
or expressed at very low levels in the human colonic mucosa under 
normal conditions, but there are findings that it is expressed in 
inflamed colonic tissues. In patients suffering from short-bowel 
syndrome (SBS), a devastating clinical problem characterized by 
diarrhea, dehydration, micronutrient depletion, and generalized 
malnutrition, the abundance of PepT1 mRNA in the colon is more 
than 5-fold that in control subjects. This up-regulation of PepT1 in the 
colon of SBS patients is an example of gut adaptation: the human 
colon can increase the luminal transport of di- andtripeptides derived 






Moreover, in patients with chronic ulcerative colitis and 
Crohn’s disease, PepT1 mediates transport of the bacteri l 
proinflammatory peptides such as formyl-methionyl-leucyl-
phenylalanine (fMLP) (Merlin et al., 2001), muramyl dipeptide 
(MDP) (Vavricka et al., 2004), and L-Ala-γ-D-Glu-meso-DAP (Tri-
DAP) (Dalmasso et al., 2010). In particular, hPepT1-mediated 
transport of fMLP, potentially stimulates expression of key accessory 
immune molecule such as MHC-1 (Merlin et al., 2001); MDP 
activates NF-kB and chemokine production (Vavricka et l., 2004). 
These data collectively indicate that, in some state  of chronic 
inflammation, hPepT1, anomolously expressed in the colon, may play 
an important role in promoting colonocyte participat on in host 
defense and pathogen clearance (Nguyen et al., 2009). 
There is no known pathology associated with the malfunction 
of the oligopeptide transporter, but a functional polymorphism in the 
PepT1 gene might be of relevance to inflammation and tibacterial 
responses in inflammatory bowel disease. In the second loop of 
hPepT1 transporter it was found a coding polymorphism, where the C 
to T nucleotide substitution corresponds to an amino acid change from 
serine to asparagines at residue 117 (Ser117Asn). This single 
nucleotide polymorphism (SNP) shows significant but reverse 
association with inflammatory bowel disease in patients from Sweden 
and Finland: the common allele C has predisposing and protective 
effects in the Swedish and Finnish cohorts, respectively. It was 
suggested that the PepT1-Asn117 variant operates a more efficient 





Other functional SNPs were identified: the variant Pro586Leu 
shows significantly reduced transport capacity (Zhang et al., 2003) 
and also for the variant Phe28Tyr altered transport of Gly-Sar and 
cephalexin is observed in various transfected mammalian cells 
(Anderle et al., 2006). PepT1 polymorphisms need additional studies, 
but it’s evident that may have an important role in translation, 
degradation and membrane insertion of the transporter and may 
contribute to disease susceptibility. 
1.4.3 Pharmacological relevance of PepT1 
The structural similarity of a variety of drugs with he basic 
structure of di- or tri-peptides explains the transport of antibiotics, 
angiotensin-converting inhibitors, and antiviral agents by PepT1. 
Moreover, the high transport capacity of PepT1 allows fast and 
efficient intestinal uptake of the drugs (Daniel, 2004). 
Classic and well-characterized drug substrates of PepT1 are the 
numerous amino beta-lactam antibiotics of the cephalosporin and 
penicillin classes (Ganapathy et al., 1995), as well as selected 
angiotensin-converting enzyme inhibitors such as captopril and the 
ester prodrugs enalapril and fosinopril. Their interaction with PepT1 
in the gut epithelium provides an oral availability generally between 
40% and 90% of a dose of these drugs (Zhu et al., 2000;Shu et al., 
2001). A variety of compounds with structures relatd to the 
cephalosporins or the ACE-ester prodrugs have also been shown to 
inhibit the peptide transporters, but their affinity s generally low 
(Daniel and Kottra, 2004). The orally active sulphonylurea 





transporters noncompetitively (Sawada et al., 1999;Terada et al., 
2000). On the other hand, a series of high-affinity-type competitive 
could be developed on basis of lysyl-dipeptides in which the side 
chain amino function is blocked with a Z or Z(NO2) group especially 
if this modification is located in the amino-terminal position of a 
dipeptide (Knutter et al., 2001;Theis et al., 2002). Other interesting 
drugs shown to be PepT1-substrates include sulpiride, a selective  
dopamine D2 receptor antagonist (Watanabe et al., 2002), and the 
dipeptide-mimetic bestatin that as a peptidase inhib tor also acts as an 
antitumor agent (Terada et al., 1997). The capability of peptide 
transporters for the uptake of d-aminolevulinic acid (ALA) can be also 
used for tumor therapy (Doring et al., 1998a;Neumann and Brandsch, 
2003). ALA is a precursor of cellular porphyrin synthesis: laser-
induced photoactivation of the accumulated porphyrins is used to 
submit tumor cells to necrosis (Kelty et al., 2002). 
In conclusion, broad substrate specificity, high transport rate 
and also a growing scientific interest in intestinal peptide transport in 
pharmacology make PepT1 a good target for efficient oral delivery of 
rational designed drugs. 




Chapter 2. Materials and Methods 
2.1 Molecular biology 
2.1.1 PepT1 cDNAs 
cDNAs encoding PepT1 were cloned in pSPORT1 vector 
between SalI and NotI sites (for rb PepT1-FLAG cDNA) (Mertl et al., 
2008) and between SalI and HindIII sites (for sb and zb PepT1 
cDNAs). 
pSPORT1 (Fig.2.1) is an expression vector that presents the 
ampicillin resistance (APr) and the reported multi cloning site (MCS). 
At both ends of the MCS there are promotor sites for T7, T3 and M13 
RNA polymerases. 
 
Fig.2.1 pSPORT1 vector. 




2.1.2 Construction of point mutations 
Mutations in rabbit PepT1 were obtained by site-dircted 
mutagenesis (Quickchange Site-Directed Mutagenesis Kit, Stratagene 
Inc., Milano, Italy). Briefly, 20 ng of the plasmid containing the 
FLAG-wild-type PepT1 cDNA (Mertl et al., 2008) were amplified 
with 2.5 units of Pfu DNA polymerase in the presence of overlapping 
primers containing in their sequence the mutated codons: 
rbPepT1 D341R: 5′-cctggtccccatcatgcgcgccgtggtgtatcc-3′ 
rbPepT1 H57R: 5’-ggacgacaacctgtccacggtcgtctaccacacgttcgtc-3’ 
rbPepT1 R282X:5′-cgcgcagatcaagatggttacgxxxgtgctgttcctgtacatccc-3′ 
where the original sequence agg was transformed in xxx that 
correspond to the following triplet for R282D gat, for R282A gcg, for 
R282E gag, for R282K aag, for R282Q gac and for R282C tgt. PCR 
amplification was performed with 25 thermal cycles of 95°C for 30 s, 
55°C for 1 min, and 68°C for 14 min. Then, 10 units of DpnI were 
added directly to the amplification reaction, and the sample was 
incubated for 1 h at 37 °C to digest the parental, methylated DNA. 
JM109 supercompetent cells were finally transformed with 1 µl of the 
reaction mixture and plated onto LB-ampicillin plates (see below for 
details). After plasmid purification, plasmid cDNAs were fully 
sequenced (Eurofin MWG Operon Biotech). 
2.1.3 Plasmid amplification, extraction and 
purification 
The vectors containing PepT1 cDNAs were introduced into
JM109 strain of E. Coli by the means of the heat-shock procedure 
following the instructions of the bacteria supplier (Promega). 




Transformed bacteria were then left to grow for about 1 h in SOC 
medium [tryptone 2% (w/v), yeast extract 0.5% (w/v), NaCl 10 mM, 
KCl 2.5 mM, glucose 20 mM], centrifuged, plated on plates 
containing selective medium (LB-Agar added with 50 µg/ml 
ampicillin) and incubated over night at 37°C. The day after, colonies 
were picked up and inoculated in liquid selective mdium (LB added 
with 50 µg/ml ampicillin). Bacteria were left to grow over night at 
37°C and then the plasmid DNA was extracted using Wizard® Plus 
SV Miniprep (Promega) following supplier’s instruction. The 
extracted DNA was loaded on a 1% agarose gel in TAE1X buffer to 
check the quality and to estimate the concentration. 
 2.1.4 In vitro transcription 
In order to achieve an efficient in vitro transcription, the clone 
containing the cDNA of interest has to be linearized in 3’ direction 
with respect to the coding region. The cDNA encoding rabbit PepT1-
FLAG transporters was linearized with NotI and the cDNA encoding 
seabass and zebrafish transporters with H nd III. 8-10 µg of plasmid 
DNA were digested, then purified using the Wizard® SV Gel and PCR 
Clean-Up System (Promega) and eluted in 35 µl of nuclease free 
water. 3 µl were loaded on a 1% agarose gel in TAE 1X buffer to 
check the linearization. The remaining DNA was used for the in vitro 
transcription as detailed described previously (Bossi et al., 2007). 
Briefly, the linearized DNA was incubated at 37°C for 3h in presence 
of 200 units of T7 RNA polymerase, 18 µl of 5X Trascription Buffer, 
8 µl of 100 mM DTT, 2.5 µl of RNasin 30 U/µl, 13 µL NTPs mix 
(ATP, CTP, UTP 10 mM and GTP 0.5 mM), 6.5 µL of 10 mM Cap 




Analog (Promega), 10 µl RNA polymerase 20 U/µl (final volume 90 
µL). After 10, 20, and 40 min from the beginning of the incubation, 1 
µL of 25 mM GTP was added to the reaction. After 1 h from the sart 
of the transcription, a mix of 4 µl of 5X TB, 1 µl of 100 mM DTT, 1 
µl of RNasin 30 U/µl, 5 µl of NTPs mix, 1 µl of T7 RNA polymerase 
20 U/µl, 1 µl of 25 mM GTP, 4 µl of nuclease-free water was added to 
each sample. At the end of 3 h, the reaction was stopped by adding 
nuclease-free to a volume of 200 µl. All enzymes were supplied by 
Promega Italia, Milan, Italy. 
The transcribed cRNA was extracted with 
phenol:chloroform:isoamyl alcohol, 25:24:1, pH 6.6, precipitated with 
LiCl 8 M and washed with 70% EtOH. The dried cRNA was then 
resuspended in a small volume of nuclease-free water nd the 
concentration estimated using a spectrophotometer (1 A260nm unit = 40 
µg/ml). 
Transcribed cRNAs had a modifications which mimic in vivo 
conditions: the process of 5’ capping. The so called “Cap Analog” is a 
modified guanine (m7G(5')ppp(5')G) which, although is not necessary 
for the protein expression, increases the translation efficiency and also 
protects the mRNA from degradation. 
2.1.5 Heterologous expression in oocytes 
 Xenopus laevis oocytes are a powerful expression system 
(Fig.2.2) with numerous advantages: i) high expression rate of 
exogenous proteins (even after only 18 hours); ii) an efficient 
biosynthetic apparatus which allows all post-transltional 
modifications necessary for the functionality and the correct targeting 




of the protein; iii) high density of proteins produced upon cytoplasmic 
mRNA injection; iv) dimensions well adapted for microinjection and 
voltage clamp; v) easiness to maintain in culture for quite long period 
(ten or more days) with no particular sterile conditions; vi) 
coexpression of different proteins in various combinations by simply 
co-injecting the respective cRNAs; vii) low expression levels of 
endogenous membrane proteins (the endogenous channels hav  been 
well characterized, thus it is easy to distinguish them from the injected 
proteins). 
 Xenopus oocytes have also some disadvantages: i) the 
expression of exogenous protein is transient; ii) the ideal temperature 
for their survival (about 18°C) is usually lower than the temperature 
appropriate for exogenous proteins (37°C for mammalian proteins) 
and this can affect the folding process; iii) although quiescent cells, 
oocytes possess their own genetic ensemble which might interfere 
with the exogenous proteins. 
 
Fig.2.2 The process of expressing exogenous proteins in Xenopus oocytes. 
 
Oocytes were prepared as detailed described previously (Bossi 
et al., 2007). Oocytes were obtained from adult female X nopus 
laevis, the frogs were anaesthetised in MS222 (tricaine 
methansulfonate) 0.10%(w/v) solution in tap water and portions of the 




ovary were removed through an incision on the abdomen. The oocytes 
were treated with collagenase (Sigma Type IA) 1 mg/ml in ND96 Ca+ 
free, for at least 1 h at 18°C. After 24 hours at 18°C in modified 
Barth’s saline solution (MBS), the healthy looking oocytes, were 
injected with 12.5 ng of cRNA in 50 nl of water, using a manual 
microinjection system (Drummond). The oocytes were then incubated 
at 18°C for 3-4 days in MBS before electrophysiological studies. The 
experiments were carried out according to the institutional and 
national ethical guidelines. 
2.2 Protein localization 
2.2.1 Single-oocyte chemiluminescence 
The expression of PepT1-FLAG isoforms at the oocyte plasma 
membrane was determined by the single oocyte chemiluminescence 
(SOC) technique (Zerangue et al., 1999),(McAlear et al., 2006;Rauh 
et al., 2010), that employs enzyme amplification with a 
chemiluminescent substrate and sensitive linear detection with a 
luminometer.  Oocytes expressing different FLAG-PepT1 isoforms, as 
well as non-transfected oocytes, were washed twice for 5 min in ice-
cold ND96 pH 7.6 and then fixed with 4% paraformaldehyde in ND96 
for 15 min at 4 ° C, rinsed 3×5 min with equal volumes of ND96, and 
then incubated for 1 hour in a 1% BSA-ND96 blocking solution (used 
in subsequent antibody incubation steps). Fixed and blocked oocytes 
were incubated for 1 h in primary mouse anti-FLAG M2 (Sigma, 
Milan Italy) monoclonal antibody 1 µg/ml in 1% BSA-ND96, washed 
6x3min in 1% BSA-ND96, incubated for 1 hour in secondary 




peroxidase-conjugated goat anti-mouse IgG 1 µg/ml, IgG-HRP 
(Jackson ImmunoResearch Laboratories), washed 6x3min in 1% 
BSA-ND96 and then 6x3min in ND96 alone. For chemiluinescence 
readings, each oocyte was transferred into a well of a 96 wells plate 
(Assay Plate White not treated flat bottom-Corning Costar) filled with 
50 µl SuperSignal Femto (Pierce); the washing solution was 
eliminated as much as possible. Chemiluminescence was quantified 
with a Tecan Infinity 200 microplate reader. The plates were read not 
later than 5 minutes after the transfer of the first oocyte. The data were 
then acquired at least three times in 10 minutes and for each oocyte 
the mean of three readings was calculated. Results were normalized to 
the mean value of wild-type FLAG-PepT1 for each batch and are 
given in relative light units (RLU). 
2.2.2 Immunohistochemistry 
Oocytes in which transport activity had been confirmed 
electrophysiologically were fixed in 100% methanol at −20°C for 2 h, 
then rehydrated at room temperature (RT) for 15 minutes in 50:50 
(v/v) methanol/phosphate-buffered saline (PBS), followed by 2x15 
minutes washes in PBS. The fixed oocytes were then embedded in 
Polyfreeze tissue freezing medium (Polysciences, Eppelheim, 
Germany) and immediately frozen in liquid nitrogen. Cryosections (7 
µm) were obtained with a Leica CM 1850 cryostat. The sections were 
incubated in the blocking buffer [2% bovine serum albumin, BSA 
(w/v), 0.1% Tween in PBS] at RT for 30 min, then the primary 
antibody, mouse anti-FLAG M2 (SIGMA, Milan Italy, 3.8 mg/mL) 
1:1000 in blocking buffer was added and incubated at RT for 1 h. 




Samples were washed 3x5 min in blocking buffer at RT. The oocytes 
sections were then incubated in the secondary antibody [CyTM 3-
conjugated AffiniPure Donkey Anti-Mouse (Jackson 
ImmunoResearch), 1.4 mg/mL, diluted 1:1000 in Blocking Buffer] at 
RT for 45 min and again washed 3x5 min with Blocking buffer. 
Images were observed with a fluorescence microscope Olympus BH2 
through a rhodamine filter set (excitation/emission filters 550/580nm). 
Images were acquired with a DS-5M-L1 Nikon digital c mera system.  
2.3 Electrophysiology and data analysis 
 Membrane electrophysiology has several advantages over 
other techniques used in transport studies: i) the membrane voltage of 
the cell is under control; ii) the temporal resolution is high; iii) the 
results may be obtained immediately, data can be analyzed and 
interpreted in real-time, and consequently the protoc ls can be 
changed or adjusted during the same experimental session. These 
benefits may be exploited in the study of transporters, thereby adding 
valuable information and significantly increasing efficiency. The 
activity of electrogenic transporters, that translocate electrical charge, 
by definition, during their working cycle, is strongly influenced by the 
transmembrane potential. Thus, tracer flux experiments suffer from 
some uncertainty, because the membrane voltage is not under control, 
and not only the value of the electrical gradient is unknown, but it is 
also bound to change as a consequence of the electrog nic activity of 
the transporter itself. A more reliable evaluation of the activity of the 
transporter is obtained instead when the membrane pot ntial is 
“clamped”.  




2.3.1 Two-Electrode Voltage-Clamp (TEVC) 
The “voltage-clamp” technique was introduced by Marmont 
and Cole (Cole and Curtis, 1941), and by Hodgkin, Huxley and Katz 
(HODGKIN et al., 1952) to study the ionic currents underlying the 
action potential in nerve axons, and it has been extended to the study 
of transporters soon after the cloning and expression of the first 
transporters in Xenopus laevis oocytes (Hediger et al., 1987;Ikeda et 
al., 1989;Parent et al., 1992;Mager et al., 1993). 
The TEVC technique is based on the use of two 
microelectrodes, one for recording the transmembrane voltage and one 
for passing current (Fig.2.3). The recorded membrane voltage is 
compared to the desired (command) voltage and a compensating 
current is automatically injected into the cell by the appropriate 
electronic apparatus. In this technique the independent (controlled) 
variable is the membrane voltage, controlled by the experimenter, 
while the dependent (measured) variable is the membrane current.  
 
Fig.2.3 Two-Electrode Voltage-Clamp. 
FBA is the feedback amplifier, E’ is the voltage elctrode and 
I’ is the current electrode. 




When a current takes place due to the activity of the transport 
systems located in the membrane, a negative feedback in the circuitry 
injects into the oocyte a current that exactly compensates the charge 
flow trough the cell membrane, in order to maintain transmembrane 
voltage under control. In addition to keeping the mmbrane potential 
constant, membrane voltage changes of any desired form can be 
applied to the cell by the TEVC technique. In the case of ion-coupled 
transporters, the transmembrane current is an indication of the 
transport activity, and the possibility of accurately controlling the 
membrane potential is particularly crucial in voltage-dependent 
processes. 
The ideal voltage clamp simply consists of a battery, a switch, 
a wire, the cell and an ammeter (Fig.2.4). Since the wire has zero 
resistance when the switch is closed, the membrane pot ntial steps 
instantly to the battery voltage. This generates an impulse of current 
that charges the membrane capacitance (Q = CmVcmd), followed by a 
steady-state current (Im = Vcmd/Rm) to sustain the voltage across the 
membrane resistance. 
 
Fig.2.4 The ideal Voltage Clamp. 




In this work some experiments were conducted in current-
clamp conditions, i.e. without strict voltage contrl, but with the 
possibility of constant current injections. 
2.3.2 TEVC experimental setup 
 A schematic view of the TEVC experimental setup used in this 
work. 
 
Fig.2.5 Schematic representation of the experimental setup. 
 
The voltage-clamp amplifier (GeneClamp, Axon Instruments 
Foster City, CA, USA or Oocyte Clamp OC-725B, Warner 
Instruments, Hamden, CT, USA) was connected to a computer 
through an AD/DA (analog-digital, digital-analog) converter 
(DIgiData 1200, Axon Instr.). This device converts the analog signal 
from the amplifier to a digital signal intelligible for the computer, and 
vice versa. Usually, signals derived from the amplifier were also 




displayed on an oscilloscope (TDS 420, TekTronix Inc., Beaverton, 
OR, USA). 
A dissection microscope (Wild M3B, Leica Microsystems AG, 
Wetzlar, Germany) was used to visualize the oocyte and 
micromanipulators (MM-33, Märtzhäuser Wetzlar GmbH & Co. KG, 
Wetzlar-Steindorf, Germany) were use to move the electrodes. A 
perfusion system consisted of a set (16) of syringes d livers the 
various solutions to the unique solution inlet of the chamber (a 
modified version of RC-1Z, Warner Instr.). All the syringes were 
connected to the inlet by the use of two manifolds (MP-8, Warner 
Instr.) and were all positioned at the same height in order to have the 
same flow rate for each solution. The recording chamber has a small 
volume (about 200 µl, 85 ml/mm height) which allows a rapid 
solution exchange (about 8-10 seconds in our system). The solution is 
aspirated by a modified acquarium pump through a suction reservoir 
connected to the oocyte well. The oocyte was placed in the chamber 
and impaled with the two Ag/AgCl electrodes. Intracellular glass 
microelectrodes were filled with KCl 3 M and had tip resistances 
between 0.5 – 4 MΩ. These resistance values were usually obtained 
by gently breaking the tips on the bottom of the chamber. Agar 
bridges (3% agar in 3 M KCl) connected the bath electrodes to the 
experimental chamber. 
All the equipments needed for the recording (the dissection 
microscope, the perfusion system, the oocyte chamber, 
micromanipulators and reference electrode) are placed inside a 
Faraday cage, in order to reduce the noise derived from 




electromagnetic fields, and on an anti vibration table. The cage and all 
the instruments inside of it were grounded. 
2.3.3 Protocols and data analysis 
In voltage-clamp mode the holding potential (Vh) was 
generally  -60 mV, unless otherwise indicated. The standard protocol 
consisted in 200 ms long pulses to test potentials from -140 to +40 
mV, in 20 mV increments. Other protocols including prepulses are 
described in the text. The current signal was filtered at 1 kHz before 
sampling at 2 kHz. 
Two methods were used to isolate the presteady-state currents 
elicited by voltage jumps (Mertl et al., 2008;Sangaletti et al., 2009): in 
the first, the slow component of a double-exponential fitting of the 
transient was taken to represent the presteady-state currents, while in 
the second, the currents remaining after subtraction of the traces in the 
presence from those in the absence of substrate werassumed to 
represent the intramembrane charge movement. The isolated  traces 
were fitted with single exponentials to obtain the time constant of 
decline, and integrated to calculate the amount of displaced charge, 
after zeroing any residual steady-state transport cur ent. The presence 
of gently decaying currents during the voltage pulse was sometimes 
observed in some mutants at alkaline pH. In these cases a sloping 
baseline was subtracted before fitting and integration. The two 
methods gave generally equivalent results; the subtraction method was 
preferred when the presteady state currents were fast, with time 
constants approaching that of the endogenous capacitive transients. 




Data were analyzed using Clampfit 8.2 (Axon Instruments), 
and figures were prepared with Origin 5.0 (Microcal Software Inc., 
Northampton, MA, USA). 
2.4 Solutions 
The oocyte culture and washing solutions had the following 
composition (in mM), ND96: NaCl 96, KCl 2,  MgCl2 1, CaCl2 1.8, 
Hepes 5, pH 7.6; MBS: NaCl 88, KCl 1, NaHCO3 2.4, Hepes 15, 
Ca(NO3)2 0.30, CaCl2 0.41, MgSO4 0.82, sodium penicillin 10 µg/ml, 
streptomycin sulphate 10 µg/ml, gentamycin sulphate 100 µg/ml, 
nystatin 10 U/ml, pH 7.6; PBS: NaCl 138, KCl 2.7, Na2HPO4 8.1, 
KH2PO4 1.9, pH 7.6. The external control solution had the following 
composition (mM): NaCl, 98; MgCl2, 1; CaCl2, 1.8. 
Different pH buffers were used for the various pH values: for 
pH 6.5, Mes 5 mM was used; Hepes 5 mM was employed for pH 7.0 
and 7.5, while for pH 8.0 the buffer was Taps 5 mM. The final pH 
values were adjusted with HCl and NaOH. Substrates w re added at 
the indicated concentrations to the appropriate solutions. 
The non-hydrolyzable substrate Gly-Sar was used for 
confirmatory intracellular injection experiments. A volume of 50 nl of 
a concentrated solution (200 mM Gly-Sar in pH 7.5 buffer) was 
injected, leading to an approximate final concentration of 20 mM 
(assuming an oocyte volume of about 500 nl). 
All substrates for electrophysiology experiments were supplied 
from Sigma, Milan, Italy. Irbesartan was from Sanofi-Aventis. 





Chapter 3. Results 
The identification of the structural basis of the functional 
mechanism of PepT1 is important because, in addition to its role in 
nutrient uptake, this transporter represents a major pathway for the 
absorption of several therapeutic drugs. Most of the above functional 
observations were derived from uptake data, in absence of control of 
the membrane voltage, or from electrophysiological measurement of 
steady transport currents, in presence of a dipeptid  substrate. 
Important additional informations regarding the transport mechanism 
may arise from measurement of presteady-state currents, the 
electrophysiological signals that can be observed in absence of 
organic substrate, and that represent the first steps in the transport 
cycle (Fesce t al., 2002;Peres et al., 2004). 
3.1 Unified modeling of PepT1 
 In PepT1 acidic pH appears to enhance the uptake of substrates 
(Fei et al., 1994;Mackenzie et al., 1996) due to the presence of an 
acidic microenvironment in the vicinity of the absorptive enterocytes 
generated by the activity of the Na+/H+ exchanger in the apical 
membrane (Kennedy et al., 2002;Watanabe t al., 2005). However, 
there are some apparently contradictory aspects: in fish species and in 
rabbits, electrophysiological measurements have indicated a 
substantially pH-independent maximal rate of transport (Steel et al., 
1997;Sangaletti et al., 2009) or even a potentiating effect of alkaline 





with human PepT1 in an extended pH range have shown a bell-shaped 
activity–pH relationship (Fujisawa et al., 2006). A similar trend has 
been found for the maximal transport current in the rabbit isoform 
(Amasheh et al., 1997). From a structural point of view, the level of 
homology among the various transporter isoforms of mammalian and 
fish species is about 56% amino acidic identity and72% similarity. 
However, these values can reach 72% and 90%, respectively, when 
considering only the human, rabbit, zebrafish, and seabass 
transporters, and limiting the analysis to the transmembrane domains 
involved in pore formation (TM 1, 3, 5, 7, 8, and 10) or to residues 
facing the pore (TM 2 and 4) (Meredith and Price, 2006). 
Electrophysiological and biophysical analyses were us d to 
compare the partial and complete transport cycles of the intestinal 
oligopeptide transporter PepT1 among three species (seabass, 
zebrafish, and rabbit). 
3.1.1 Presteady-state currents in the different 
species 
The PepT1s of rabbit (rbPepT1), seabass (sbPepT1), and 
zebrafish (zfPepT1) exhibit presteady-state currents in the absence of 
organic substrate. Fig.3.1 compares the currents induced in each 
isoform by voltage pulses in the absence and presenc  of saturating 
Gly-Gln at pH 6.5. Although experiments have been prformed in a 
more extended range (6.0–8.0), pH 6.5 seems real physiological 
conditions, at least in rabbit PepT1 (based on the pH of the luminal 







Fig.3.1 Comparison of PepT1 presteady-state currents from three 
species. In the absence of organic substrate (top row), all three transporters 
display slowly decaying transients in response to “on” and “off” voltage 
steps. The bottom row shows the steady currents induced in the same oocytes 
by the addition of 3 mM Gly-Gln and the simultaneous disappearance of the 
presteady-state currents. 
 
Although the presteady-state currents of rbPepT1 and sbPepT1 
have already been described and analyzed (Nussberger t al., 
1997;Sangaletti et al., 2009), information on zfPepT1 is lacking. As 
shown in Fig.3.1 (top row), the two fish species, exhibited larger 
currents for hyperpolarization than for depolarizations, while the 
transients  from  rbPepT1 are  approximately symmetrical around   the 
-60 mV holding potential. Adding saturating amounts of organic 
substrate (3 mM Gly-Gln) elicited steady transport currents (Fig.3.1, 
bottom row) and, as commonly observed in most electrogenic 
transporters, abolished the presteady-state currents.  
The presteady-state currents were separated from the fast peaks 
due to the endogenous oocyte capacity, using two different procedures 
(see Materials and Methods for details). In the first, a double 














absence of substrate. In the second, the current traces in the presence 
of saturating substrate have been subtracted from th se in its absence 
and a single exponential fitted to the difference. In both cases, steady 
transport currents were subtracted before fitting the exponentials. 
As previously observed (Mertl et al., 2008;Sangaletti et al., 
2009), the two methods give virtually identical result . This is relevant 
not only to better understand the transporter mechanism, but is also 
important because of the intrinsic limitations of the two-exponential 
method. Namely, the separation of two exponentials by fitting is 
impossible when the two time constants are close in value. Because 
the time constants for charging the oocyte membrane capacity are 
generally around 1 ms, the two-exponential method becomes 
unreliable when the decay time constant of the presteady-state 
currents approaches this value (i.e., 2–3 ms). Thisis ndeed the case 
for both fish species at the most positive potentials explored (see 
below). In addition, both rabbit and seabass PepT1 exhibit an 
acceleration of the presteady-state current decay at alkaline pH 
(Nussberger et al., 1997;Sangaletti et al., 2009). For these reasons, the 
subtraction method has been used to isolate these curr nts. Because 
the presteady-state currents of seabass and zebrafish are very similar 
to each other and the results from seabass PepT1 have previously been 
published (Sangaletti et al., 2009), only data from zebrafish are shown 
here. 
The voltage dependences of the decay time constant τ d the 
intramembrane charge movement Q obtained from the isolated 






Fig.3.2 Effects of external pH on the properties of the prsteady-state 
currents. In all species, external alkalinization shifts the time constant vs. 
potential (τ/V) and the charge vs. potential (Q/V) curves toward more 
negative potentials. Furthermore, the time constant of decay is strongly 
reduced. In the rightmost column, the unidirectional rate constants of the 
intramembrane charge movement are shown. 
 
Several observations can be made when comparing the time 
constant vs. potential (τ/V) and charge vs. potential (Q/V) curves of the 
rabbit and fish PepT1. First, as already mentioned, at pH 6.5, the 
rbPepT1 transients are more symmetrical around the holding potential; 
this is confirmed by the position of the bell-shaped τ/V curve with a 
maximum at about -90 mV. For the fish transporters, only the right 
half of the bell-shaped curve is visible in the voltage range that can 
reasonably be explored; the seabass transporter appears to have a 
maximum at about -140 mV (Sangaletti e  al., 2009), whereas the 
maximal τ for the zebrafish isoform may be at even more negative 
voltages. Similarly, the Q/V curves for rbPepT1 show a clear 









































































































sigmoidal shape, whereas in the fish transporters only the rightmost 
part of a sigmoid is detectable. Therefore, the prope ties of the fish 
PepT1s are shifted to more negative potentials compared to those of 
the rabbit isoform.  
Furthermore, from the τ/V and Q/V curves it is possible to 
derive (Fesce et al., 2002) the unidirectional rate constants of the 
























The decay rates of rbPepT1 transient currents are much slower than 
those of both fish transporters, with sbPepT1 faster than zfPepT1 
(Sangaletti et al., 2009). 
3.1.2 Effects of external pH on the presteady-state 
currents 
Alkalinization of the external medium has been shown to produce 
negative shifts in the τ/V and the Q/V curves in rabbit and seabass 
PepT1 (Nussberger et al., 1997;Sangaletti et al., 2009). This effect 
was also seen in zfPepT1. Fig.3.2 compares these results between the 
fish and rabbit isoforms. 
The equilibrium distribution of the charge moved during the 




















Q ,           [eq.3.2] 
where Qmax is the maximal moveable charge; V0.5 is the voltage at 
which half of the charge is moved (that is, the midpoint of the 
sigmoidal); and σ = kT/qδ represents a slope factor, in which q is the 
elementary electronic charge, k is the Boltzmann constant, T is the 
absolute temperature, and δ is the fraction of electrical field over 
which the charge movement occurs. Fitting the Q/V curves to this 
equation gives the parameters summarized in Tab.3.1. 
      Rabbit              Seabass     Zebrafish 
pH 6.5 7.5 6.5 7.5 6.5 7.5 
Qmax (nC) 33.2 ± 1.9 31.5 ± 1.2 10.2 ± 0.2 6.8 ± 0.9 11.0 ± 0.3 9.9 ± 1.1 
V0.5 (mV) -41.4 ± 2.5 -100 ± 2.3 -98.7 ± 1.3 -122.0 ± 0.6 -108 ± 1.6 -119 ± 7.2 
σ (mV) 42.9 ± 3.1 39.5 ± 1.7 23.1 ± 0.7 23 ± 2.7 31.1 ± 0.9 33.5 ± 3.3 
 
Tab.3.1 Boltzman equation parameters. 
 
The higher value of σ in the rabbit form suggests that charge 
movement may occur over a smaller fraction of the mmbrane 
electrical field in rabbit than in the two fish species. 
The sigmoidal Q/V curve may represent the steady-state 
distribution of the transporter molecules between two conformations 
with the center of charge in two different locations of the membrane 
electrical field. The charge movement process may be described with 
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Qin and Qout are the amount of charge at an inner and outer position, 
respectively, in the membrane electrical field. It is easy to derive 















where Qmax is the maximal moveable charge, obtained from the 
saturating values of the Q/V sigmoidal curve. 
In all transporters, alkalinization sped up both the inward and 
outward rates, although the effect on this last parameter was much 
larger (Fig.3.2, bottom row). Notably, the voltages at which the in and 
out rates crossed showed the same shifts as the V0.5 values. 
These observations indicate that protonation of unide tified 
amino acids slows down the rates of the charge-moving 
conformational changes induced by membrane potential. Indeed, the 
much slower value of the decay time constant for rbPepT1 may be 
explained by its higher isoelectric point (Daniel et al., 2006); at the 
same pH, it will be protonated to a higher degree than will sbPepT1 
and zfPepT1. Its movements in response to voltage changes will occur 
less frequently for this reason. 
3.1.3 Modeling PepT1 presteady-state currents 
A kinetic scheme has been deviced to simulate the observed 
results, particularly those showing a pH-dependent increase in both 
unidirectional rate constants. To incorporate the slowing effects of 
protonation on both unidirectional rate constants, some changes were 
made to existing models (Mackenzie et al., 1996;Nussberger et al., 





occurs between states 1 and 6, and the rearrangement of the empty 
transporter displaces an intrinsic net negative charge in the membrane 
field. This transition is bracketed by two proton-bound states (T2 and 
T7) effectively modulating the T1 ↔ T6 transition (see below).  
 
Fig.3.3 Minimal kinetic scheme used to simulate the effect of external pH on 
the presteady-state currents of PepT1 transporters. Transitions T1↔T6 and 
T3↔ T4 are voltage-dependent. In the absence of organic substrate (S), the 
only possible states are T1, T2, T5, T6 and T7. External protons can bind to 
T1 (leading to state T2) and to T6 (leading to state T7). T2 and T7 act as 
traps, effectively slowing down both inward and outward charge movement. 
 
Extracellular oligopeptides bind to state T2, leading to state T3 
and causing a partially voltage-dependent conformation l 
rearrangement from T3 to T4, a state from which the organic substrate 
is released intracellularly (T5). The subsequent release of H+ leads to 
the inward-facing, empty transporter (state T6).  
The introduction of the protonated state T7 is justified by the 
need to reproduce the slowing action of external protons on the inward 
rate of charge movement, observed especially in the fish isoforms 
(i.e., the transition T6 → T1). External protons “sequester” the 
transporter in this state, effectively slowing down the return from the 
inward- to the outward-facing conformation. The transition to state T7 





been suggested (Verri et al., 2003), to account for the smaller 
transport current observed at acidic pH in the zebrafish PepT1. 
The set of differential equations describing the complete scheme 

















































      [eqs 3.4] 
where T1–T7 are the probabilities that the transporter is in a given 
state, and the k values are the rate constants, either dependent or 










































































































The unidirectional rate constants of Fig.3.2 were fitted with 
growing and decaying exponentials in the form 
( )kTqVoutrateoutrate out /exp0 δ=   
and             [eqs 3.5]
( )kTqVinrateinrate in /exp0 δ−= , 
where outrate0 and inrate0 are the zero-voltage rates; q, k, and T have 
the same meaning as in eq.3.2; and outδ and inδ  (with δδδ =+ inout  
in eq.3.2) are the asymmetric fractional dielectric distances. 
Rates k16, k61, k12, k21, k67, and k76 were determined based on the 
effects of voltage and external pH on the unidirectonal rate constants 
of Fig.3.2. Assuming that the binding/unbinding of protons in 
transitions T1 ↔ T2 and T6 ↔ T7 is much faster than in T1 ↔ T6, 
the unidirectional rate constants of charge movement outrate and 


























are modulating factors that depend on the external proton 
concentration (Chen et al., 1996). Because k12 and k67 (but not k21 and 
k76) increase with acidity, the modulating factors will reduce the 
values of both outrate and inrate. 
The values of k56 and k65 were adjusted to account for the effects 
of internal pH (Nussberger et al., 1997), assuming a fixed value of 






were handled together, and a “generalized” fish transporter was 
modeled (Tab.3.2). 
Fig.3.4 shows the results of the simulations for rabbit and the 
generalized fish transporter. Clearly, the simulations are in very good 
qualitative and, for rabbit PepT1, also quantitative agreement with the 
experimental results shown in Fig.3.2. 
 
Fig.3.4 Simulated traces of presteady-state currents at two external pH 
values for rabbit (A) and generalized fish (B) PepT1. he traces were 
analyzed following the same procedure as that used for the experimental 
subtracted recordings to produce the curves shown in the bottom graphs. 
3.1.4 Transport currents of PepT1 
The transport currents generated by rabbit, zebrafish, and seabass 
PepT1 have been previously studied (Steel et al., 1997;Kottra and 
Daniel, 2001;Verri et al., 2003;Sangaletti et al., 2009). These three 
isoforms show a similar trend: in all cases, acidic external pH 
increases substrate affinity, but it either decreases (Kottra and Daniel, 







































































2001;Verri et al., 2003) or does not affect (Steel et al., 1997;Sangaletti 
et al., 2009) the maximal current. These features are illustrated in 
Fig.3.5 for the rabbit transporter; very similar curves can be observed 
for the zebrafish (Verri et al., 2003) and seabass isoforms (Sangaletti 
et al., 2009). In human PepT1, on the other hand, high acidity 
increases both substrate affinity and Imax (Fei et al., 1994;Mackenzie t 
al., 1996). 
 
Fig.3.5 Transport-associated current from rabbit PepT1. op row: I/V 
relationships of the transport-associated currents (substrate present minus 
substrate absent) at pH 7.5 (A) and 6.5 (B). Bottom row: values of Imax (C) 
and K05 (D) obtained by fitting the concentration-current relationships from 
(A and B) with the Michaelis-Menten equation. 
 
Another interesting feature apparent in Fig.3.5 is the presence of 
a small outward current, especially at low substrate concentration and 































































































alkaline pH (see below). This effect has also been reported for the 
zebrafish transporter (Verri et al., 2003), but not for the seabass or 
human transporters (Mackenzie et al., 1996;Sangaletti et al., 2009). 
The decrease in Imax at acidic pH in rabbit and fish transporters is 
unexpected given that the inwardly directed proton electrochemical 
gradient increases. This effect, however, might be explained by a 
decreased cycling rate related to the slowing of the c arge movement 
caused by protonation. In the case of inward substrate transport, the 
transport cycle is circulated only in a clockwise direction, i.e., the 
transition of the empty transporter occurs in the T6  T1 direction, 
showing large pH dependency (Fig.3.2, bottom row). 
A useful index of the overall transport efficiency is given by the 
ratio Imax/K05, which is the slope of the Michaelis-Menten relationship 
at zero substrate concentration. The largest difference in efficiency, in 
favor of the more acidic solution in the physiological range of 
membrane potential, was observed in the rabbit transporter; there was 
no significant difference in the zebrafish. This is in line with the acidic 
pH of the small intestine of rabbit but alkaline pH in zebrafish 
(Nalbant et al., 1999). 
 
Fig.3.6 Transport efficiency. Plots of the ratio of relative Imax/K05 for rabbit 
(A) seabass (B) and zebrafish (C). 









































































3.1.5 Transport current modeling 
Kinetic models for human and rabbit PepT1 have been proposed 
(Mackenzie et al., 1996;Irie et al., 2005;Sala-Rabanal et al., 2006); 
however, none have been tested thoroughly on rabbit or fish 
transporters to verify their ability to simulate the main aspects of 
transporter functioning. Therefore, the presteady-state current model 
developed above has been tested to determine its ability to simulate 
the characteristics of the transport-associated currents. Only the 
essential states necessary to complete the transport cycle were added, 
namely states T3 and T4, corresponding to the outward- and inward-
facing conformations with bound substrate. Because the best fit of the 
experimentally observed charge movement required transition T1 ↔ 
T6 to occur over 71% of the membrane electrical field for rabbit and 
87% for fish (Tab.3.2), the remaining fractional voltage-dependence 
for protons was attributed to the T3 ↔ T4 transition.  
The additional kinetic parameters necessary to account for 
substrate binding and translocation are shown in Tab.3.3. 




43 k45 k54 δ34 
Units M-1s-1 s-1 s-1 s-1 s-1 M-1s-1  
Rabbit 2 x 105 20 6000 6000 5000 3.49 x 1011 0.29 
Fish 8 x 106 20 6000 6000 5000 8.89 x 1010 0.13 
 
Tab.3.3 Additional parameters in presence of substrate. 
 
The parameters used to simulate the presteady-state currents (Tab.3.2) 
were not modified. In particular, k23 and k32 were chosen to give a 
value of K05 consistent with the experimental observations at pH 6.5, 
and k34 and k43 were set to be equal to each other at 0 voltage and were 





value, while k54 was derived from the other rates to satisfy the 
principle of detailed balance (Hille, 2001). 
Fig.3.7 illustrates simulations showing the model’s ability to 
reproduce the main findings for transport-associated currents in the 
different species, that is, the effects of external pH on the Michaelis-
Menten parameters Imax and K05. These parameters were obtained by 
applying the same procedure used for the experimental data: the I/V 
curves corresponding to various substrate concentrations (0.03–10 
mM) were generated by numerical simulations and then Imax and K05 
were obtained by fitting the dose–current curves at each potential with 
a Michaelis-Menten equation. The left column in Fig.3.7 simulates the 
rabbit transporter. At alkaline pH, Imax appears to remain constant 
(Steel et al., 1997) or to slightly increase (Kottra and Daniel, 2001), 
while the apparent affinity decreases (higher K05). Both experimental 
observations are reproduced by the model, although the K05 
simulations are not completely satisfactory (Fig.3.5), possibly because 
“zero trans” conditions were assumed in calculations, whereas 
substrates can be expected to accumulate in the intracellular 
compartment near the membrane in real measurements. The central 
column of the figure represents the generalized fish transporter 
(Tab.3.2 and Tab.3.3). Again, the model reproduced the unique 
features of this transporter, namely, the increase in Imax at alkaline pH 
and the affinity decrease common to all species. To stress the 
versatility of the model, an opposite effect on Imax has been simulated, 
such as the increase observed with acidity in human PepT1 
(Mackenzie et al., 1996): this is shown in the right column of Fig.3.7, 





was obtained using the rabbit kinetic parameters with a single change: 
a reduction of k67 from 5*10
8 to 1*108 (Tab.3.2) is sufficient to 
produce an opposite effect of pH on Imax. 
 
Fig.3.7 Simulations of the Michaelis-Menten parameters. Imax and K05 were 
obtained by analyzing the dose-current curves generated by the model, 
using the rate values indicated in Tables 3.2 and 3.3 for rabbit (left column), 














































































































3.2 Electrostatic gates in PepT1 
Mutations of single amino acids may result in considerable 
changes of the transport function of nutrient transporters. In the case 
of PepT1, the conserved residue His 57, residing in the second 
transmembrane segment, as well as the corresponding residue His 87 
in PepT2, were found to be essential for the functio ing, whereas 
tyrosine residues adjacent to H57 seem to stabilize the cotransported 
proton when interacting with H57 (Terada et al., 1996;Fei et al., 
1997). The nearby histidine residue His 121 (and His 142 in PepT2) is 
not essential, but influences the substrate binding, as H121 mutants 
have shown decreased affinities (Chen t al., 2000). The tyrosine 
residue Y167 has an important function as well, since its mutation to 
alanine completely abolished transport via PepT1 (Yeung et al., 
1998). By using the cysteine scanning method Kulkarni and 
coworkers identified in the transmembrane segments 5 and 7 several 
residues important for the transport function and suggested that these 
segments line the putative aqueous channel (Kulkarni et al., 2003b). 
Finally, the same authors identified two oppositely charged residues 
(R282 and D341) in the transmembrane segments 7 and 8, 
respectively, that form a salt bridge and play an important role in the 
substrate translocation via PepT1 (Kulkarni et al., 2007). Interestingly 
mutation Arg282Glu appeared to convert the cotransporter in a 
substrate-gated, rather unspecific cation channel (M redith, 2004;Pieri 
et al., 2008). In addition, this mutation caused loss of sensitivity to 
pH. 
Therefore the properties of the presteady-state currents in the 




current in these mutants were studied in parallel, in the attempt of 
gathering a more complete picture of the roles of these residues.
position of these two residues is shown in Fig.3.8
Fig.3.8 Representation of the 12 TMDs topology of PepT1 and indication of 
3.2.1 Presteady
mutants 
Considering that the presteady
believed to be mostly due to the rearrangement of charges intrinsic to 
the transporter (Mackenzie 
behaviour of charge
(R282D, R282E and D341R)
conservative mutation R282K, and the substitution of arginine 282 
with the non-charged non
. The properties of the transport-associated 
. 
the position of the FLAG-tag. 
-state currents in charge-pair 
-state currents of PepT1 are 
et al., 1996;Nussberger et al., 1997
-reverting mutants in these positions of rbPepT1 
 has been examined, as well as the 










polar glutamine (R282Q). Furthermore, the essential h stidine 57 
(H57R) and the double mutant R282D-D341R have been tested. 
Fig.3.9  shows representative traces from the various soforms. 
All R282 mutants were able to generate presteady-state currents in 
absence of substrate, as well as transport-associated currents with 
amplitudes comparable to the wild-type, while the currents observed 
in the D341R form were smaller, and neither transporter-related nor 
presteady currents could be observed in the double mutant R282D-
D341R and in H57R. 
 
Fig.3.9 Current responses to voltage pulses in absence and presence of 
























3.2.2 Localization and membrane expression of the 
FLAG protein 
Immunolocalization experiments were performed to 
understand whether the various mutants were correctly inserted in the 
oocyte membrane. Representative images are shown in Fig.3.10 A. 
The negative controls (non-injected oocytes and oocytes expressing a 
wild-type transporter with no FLAG), gave no visible signal in the 
membrane of the oocytes. All the other isoforms were correctly 
localized in the membrane to a variable extent. These observations 
were confirmed by the single-oocyte chemiluminescence (SOC) 
experiments that were performed on larger numbers of oocytes from 
different batches (Fig.3.10 B). All functional mutan s were present in 
the membrane at levels similar or greater than the wild-type, in 
agreement with previous results (Kulkarni et al., 2007). Our data also 
confirm the correct membrane localization of the non-functional 
mutant H57R (Uchiyama et al., 2003). However, the double mutant 
R282D-D341R gave only very weak signals in both the 
immunolocalization and in the chemiluminescence experiments, in 







 rbPepT1wt and mutants surface expression. 
(A) and chemiluminescence experiments (B) 











These results are generally well correlated to the 
electrophysiological observations: the lack of transporter-associated 
currents seen in the R282D-D341R double mutant is paralleled by the 
weak luminescence signal in Fig.3.10 for this isoform, while the large 
currents displayed by the R282 mutants are in agreement with the 
strong signals of the localization and luminescence experiments. On 
the contrary the small presteady-state and transport cur ents recorded 
in the H57R and D341R forms are in contrast with the large 
membrane expression seen in the results reported in Fig.3.10. Based 
on these observations, the reduced functionality of this last mutant 
appears to be attributable to a defect in the molecular mechanism 
rather than to insufficient targeting to the membrane. 
The presteady-state currents generated by the functional 
mutants maintained the sensitivity to external pH by showing a shift 
towards more negative potentials at more alkaline pH, as illustrated in 
Fig.3.11 for the R282D mutant. The isolated currents were analysed as 
explained in the Method, and the results of this analysis are plotted in 
the bottom row of Fig.3.11, showing the accelerating action of 
alkaline pH on the time constant and the shift towards more negative 
potentials induced by this pH on both τ/V and Q/V curves. Fitting a 
Boltzmann equation [eq.3.2] to the R282D data of Fig.3.11 gives V0.5= 
-45 ± 0.9 mV at pH 7.5, and 7.8 ± 6 mV at pH 6.5 in this group of 
oocytes. The estimated maximal moveable charge appears to remain 
substantially constant (41.4 ± 0.8 nC at pH 7.5 vs 37.6 ± 3.1 nC at pH 
6.5), although these data are subject to significant errors especially at 
pH 7.5 because of lack of saturation at positive potentials. The 





that at the same pH the decay time constants of the R282D mutant are 
shorter and that both τ/V and Q/V curves of the mutant are shifted 
towards more positive potentials (V0.5 = -59.2 ± 1.3 mV at pH 6.5 in 
this group). These effects were also seen, to a various degree, in all 
other arginine mutants. 
 
Fig.3.11 Mutants in the charge-pair residues were pH-sensitive. 
Top row: traces of pre-steady-state currents isolated using the subtraction 
method in a representative oocyte expressing the rabbit R282D mutant at the 
two indicated pH values. Bottom row: values of the time constant of decay 
and of the amount of displaced charge in the two pH. 
3.2.3 Unidirectional rates 
A more complete analysis of the charge movement properties 
of the different isoforms at pH 6.5 is shown in Fig.3.12. Here the Q/V 
curves are plotted as the amount of charge displaced in an inner 
position in the membrane electrical field, relative to the maximal 









































displaceable charge (Qmax), obtained from fitting Boltzmann equation 
[eq.3.2] to the sigmoidal curves (Fesce et al., 2002). Fitting the Q/V 
curves in Fig.3.12 A to this equation gives, for the various isoforms, 













































Tab.3.4 Boltzman equation parameters. 
 
It may be seen that in all arginine 282 mutants the Q/V curves 
are shifted towards more positive potentials compared to the wild-
type, and the time constants are shorter. Conversely, replacement of 
the negative aspartate 341 with arginine causes a ng tive shift of both 
τ/V and Q/V curves together with an increase in the maximal time 
constant value (Fig.3.12 A and B). 
With the partial exception of the D341R mutant, no strong 
changes in the slope factor σ can be seen in Tab.3.4, implying that the 
mutated residues are only marginally (if at all) involved in the charge 
movement underlying the presteady-state currents. 
From the data in Fig.3.12 A and B, the plots of inrate and 
outrate for the wild-type and the six functional mutants can be 
obtained (Fig.3.12 C and D). These graphs show that, compared to the 
wild-type, the mutants of R282 exhibit faster inward and slower 






Fig.3.12 Charge movement analysis. A and B: relative amount f moved 
charge and decay time constant, respectively for the indicated isoforms at 
pH 6.5. C and D: outward and inward rate constants. 
 
3.2.4 Transport currents 
To complete the analysis of the electrophysiological properties 
of the charge-pair mutants, experiments have been performed to 
compare the characteristics of the transport-associated current, and 
their possible correlations to the presteady-state currents. 
The top row of Fig.3.13 shows the records of the isolated transport 
currents (obtained by subtracting the currents in absence of substrate 
from those in presence of 1 mM Gly-Gln) in four repr sentative 
oocytes expressing the WT PepT1, the R282D, the R282A, or the 







































































D341R mutant, each tested with the usual pulse protocol at external 
pH 7.5. In the bottom row of Fig.3.13 the average I/V curves at four 
pH values (6.5, 7, 7.5 and 8) are plotted. The graphs are normalized to 
the current value at -140 mV (pH = 7.5) for a more easy comparison; 
however it must be remembered that the currents generated by the 
D341R mutant were significantly smaller in absolute value (see 
Fig.3.9). In all isoforms, changes in external pH caused shifts in the 
I/V curves that were in the same directions as for the presteady-state 
currents parameters. This observation indicates that t e substrate 
transport activity is still pH-dependent in these three mutants. At 
potentials more positive than -40 mV, the shape of the relationships 
shows inward rectification in the wild-type and particularly in the 
D341R mutant, while it is much more linear in the R282D and R282A 
forms, that show a very clear reversal and strong outward currents. 
Indeed reversal of the transport current is seen also in the wild-type 
transporter at pH 8 (squares in Fig.3.13). 
The transport current generated by the R282K mutant was 
qualitatively similar to that of the wild-type, while the behaviour of 
the R282E and R282Q mutants was comparable to R282D and 
R282A, respectively, with evident outward currents and clear shifts in 
Erev induced by changes in pH and substrate concentration. For the 
non-conservative arginine mutants, semilog plots of Erev vs. pH were 
linear (R > 0.98) with slopes between -38.2 (R282D) and -49.6 
(R282A) mV/pH unit (Fig.3.14 A), indicating a substan ial 
contribution of protons to the current. It may be relevant to note that 
the amplitude of the outward current and the positin of the reversal 





of expression of the transporters ((Kottra et al., 2002) and our 
observation in 3.3). 
 
Fig.3.13 Transport currents in the different isoforms. 
Top row: subtracted traces (1 mM Gly–Gln minus no substrate) at pH 7.5 
from four representative oocytes expressing the indicated transporters. Note 
the slow decay in the current traces exhibited by the R282D and R282A 
mutants (arrows). Bottom row: I–V curves elicited by 1 mM Gly–Gln in the 
four isoforms at different external pH values. 
 
The estimation of the apparent affinity for external protons is 
made difficult by the presence of the outward currents (see below). 
However, limiting the analysis to the wild-type, the proton 
concentrations eliciting half the maximal current increase with voltage 
from 15 nM at  -120 mV to about 770 nM at -120 mV (Fig.3.14 B), in 
qualitative and quantitative agreement with previous determinations 











































































































Fig.3.14 A: pH dependence of reversal potential in the non-c servative 
arginine mutants. B: Apparent affinity for protons for the wild-type PepT1. 
 
Changing the dipeptide concentration at constant pH produces 
on the transport currents the effects illustrated in Fig.3.15 for the wild-
type and the R282D mutant (very similar results were seen in the 
R282E, R282Q and R282A forms). Higher substrate concentrations 
applied at pH 7.5 produce an increase in current amplitude that 
reaches saturation at 1 mM in the wild-type, and shifts the reversal 
potential towards more positive values in all isoforms. Indeed, at this 
pH and using lower substrate concentrations, a clear reversal of the 
current is visible also in the wild-type, confirming previous 
observations (Verri et al., 2003;Kottra et al., 2009). The fact that 
changes in the concentration of a neutral  substrate, such as Gly-Gln, 
are able to affect Erev suggests that the organic substrate is translocated 
as a complex with the electric charge, confirming that these mutants 




































Fig.3.15 Effects of changing the external Gly-Gln concentration on the 
current and the conductance at fixed pH (7.5) in the wild-type (A) and 
R282D (B) PepT1. Increasing [Gly–Gln]shifts Erev towards more positive 
values. C and D: dose–conductance curves for the two isoforms. 
E and F: voltage dependence of the maximal conductance (Gmax) and 
substrate concentration producing half Gmax (K05) obtained by fitting 
Michaelis–Menten equations (continuous curves) to the data in C and D (for 
clarity only the data at −140, −100, −60, −20 and + 20 mV are shown). 
 































































































































The reversal of the current direction complicates the evaluation 
of the apparent affinity for the substrate from theusual current-dose 
plots. An alternative possibility to gain informations on the ability of 
the transporter to interact with the substrate is the use of the chord 
conductance (G) as an indicator of the level of activity. The chord 






   
This quantity is directly proportional to the transport current, but it 
remains always positive, being divided by the electrochemical 
gradient. Fig.3.15 C and D plot this quantity against the substrate 
concentration. Fitting these plots with a Michaelis-Menten equation 
gives the values of the maximal conductance (Gmax) and of the 
substrate concentration producing half Gmax (
GK05). These graphs are 
shown in Fig.3.15 E and F. It may be noted that the diff rent voltage-
dependence of Gmax in the two isoforms reflects the opposite curvature 
of the I/V plots in Fig. 3.15 A and B. ClearlyGK05 cannot be directly 
compared to the apparent affinity classically obtained as the substrate 
concentration producing the half-maximal current (Mackenzie et al., 
1996;Kottra and Daniel, 2001). However in the present context the 
aim of this analysis was to compare the properties of the mutants with 
those of the wild-type. Fig.3.15 F shows that GK05  for the R282D 
mutant is greater than for the wild-type over most f the voltage 








3.2.5 Charged substrates 
PepT1 transporters are known to accept as substrates several 
di- and tri-peptides possessing different electrical ch rge, provided the 
charged amino acid is in the amino-terminus position (Kottra et al., 
2002). Therefore the behaviour of the charge-pair mutants has been 
tested in the presence of the dipeptides. Lys-Gly, and Asp-Gly, in 
addition to Gly-Gln. The results are shown in Fig.3.16 for the wild-
type and the mutants D341R, R282Q, R282D and R282K. As in the 
other experiments illustrated above, R282E and R282A behaved quite 
similarly to R282D and to R282Q respectively. 
The inward rectifying characteristic of the wild-type, D341R 
and R282K transporters appears to be independent on the charge 
carried by the substrate. In all isoforms, Asp-Gly elicits smaller 
transport currents at this pH (7.5) compared to Gly- ln. On the 
contrary the currents produced by Lys-Gly are larger in all cases, 
reaching amplitudes about twice or more that of the neutral Gly-Gln in 
the non-conservative arginine mutants. These results confirm previous 







Fig.3.16 Voltage dependence of the transport currents elicit d by differently 
charged dipeptides (all at 1 mM) in the indicated mutants at pH 7.5. 
 
The potency order of the substrates remains unchanged in all 
functional mutants, compared to the wild-type. However, a closer look 
at the graphs reveals more subtle differences: the degree of reduction 
(compared to Gly-Gln) of the negatively charged dipeptide is greater 
in the non-conservative arginine mutants and smaller in the D341R 
form. Conversely, in these mutants Lys-Gly produces a substantially 





























































































































3.3 Reverse operation in PepT1 
The question of reverse operation is a relevant issue in many 
cotransport systems, especially in the context of neurological 
disorders in which leakage of neurotransmitters into the extracellular 
space may have profound consequences. Although the physiological 
role of these transporters is the reuptake, in several instances a release 
of neurotransmitter via the transporter has been report d. This 
reversed mode of operation may be either the effect or the cause of 
abnormal or pathological conditions. In the case of the glutamate 
transporters, export of glutamate may lead to the elevated extracellular 
levels that cause excitotoxicity (Rossi et al., 2000), while in the SLC6 
family reversal of the operation of the dopamine transporter is caused 
by amphetamines (Khoshbouei et al., 2003) (Seidel et al., 2005), and 
release of GABA through GAT1 has been hypothesized to concur in 
causing epileptic seizures (Richerson and Wu, 2003;Richerson and 
Wu, 2004).  
Although the SLC15 family is distinct from the gene families 
of the neurotransmitter transporters cited above (SLC1 and SLC6), 
there is growing evidence that different families may share common 
structural modules (Meredith and Price, 2006;Abramson and Wright, 
2009;Krishnamurthy et al., 2009). It is conceivable therefore that an 
investigation on the structural determinants of reve se operation in 
PepT1 may contribute to understand the same process in the 
neurotransmitter transporters. Furthermore, the renal isoform of the 
peptide transporter, PepT2 has been identified among others in the 





neurons and could play a role in both release and reabsorption of small 
neuropeptides (Rühl et al., 2005). 
Outward currents have been observed, under certain 
experimaental conditions, in the zebrafish isoform of PepT1 (Verri et 
al., 2003), and also in a mammalian isoform (Kottra et al., 2009). 
Interestingly, in this last case it was reported that t e outward currents 
were greatly enhanced in conditions of high intracellular substrate 
concentration, or following inhibition of intracellu ar dipeptide 
hydrolysis. 
The two rbPepT1 mutants in arginine 282 (R282D and R282A) 
exhibit large outward transport currents that remain pH- and substrate 
concentration-dependent. An analogous mutant (R282E) of rabbit 
PepT1 was previously reported to exhibit characteristics similar to a 
substrate-gated unspecific cation channel (Meredith, 2004). Therefore 
the properties of reverse operation in the R282D and R282A mutants 
have been investigated to understand to what degree the operation of 
PepT1 was modified from a coupled-transport mode to a channel 
mode, obeying the principles of electrodiffusion.  
The hypothesis of an important role of local 
accumulation/depletion of substrate near the intra- and extracellular 
sides of the transporter, previously suggested (Kottra and Daniel, 
2001), was tested by employing different experimental protocols, 
aimed at altering the transport regime by long lasting holding 
potentials. 
PepT1 transporters show relatively poor substrate specificity 
(Vig et al., 2006): many di- and tri-peptides, either neutral or 





tetrapeptides are not (Herrera-Ruiz and Knipp, 2003;Daniel et al., 
2006). Having observed enhanced outward currents in mutants in 
which the positive R282 was removed, the importance of a charge in 
the substrate was also investigated, using both positively and 
negatively charge dipeptides, in addition to the zwitterionic Gly-Gln. 
3.3.1 Outward transport currents of PepT1 in 
experimental conditions 
Outward transport currents have been observed in wild-type 
PepT1 when depolarizing pulses of relatively short du ation (50 – 250 
ms) are applied with the voltage-clamp technique from negative (-40, 
-60 mV) holding potentials (Kottra and Daniel, 2001) (Verri et al., 
2003;Kottra et al., 2009). Outward currents are most easily seen at 
alkaline pH and relatively low substrate concentrations, since 
increasing the concentration of either substrate or H+ shifts the 
current-voltage relationships to more positive potentials, eventually 
bringing the reversal potential (Erev) out of the experimental range 
(Verri et al., 2003) and our unpublished observations). In addition to 
the results in wild-type PepT1, some mutants in arginine 282 are also 







Fig.3.17 A: Transport currents recorded in the presence of 1 mM Gly-Gln in 
the wild-type and indicated mutants at pH 8.0. B: I/V relationships.  
C: Surface expression, reported as results of the chemiluminescence 
experiments. 
 
The I/V relationships plotted in Fig.3.17 B show that in the 
same conditions of pH and substrate concentration the value of Erev 
becomes progressively more negative as the positive charge of 
arginine is first neutralized to alanine and then changed in sign with 
aspartate. Moreover, the R282D mutant (but not R282A) generated 
significantly larger currents than the wild type. On the contrary, 
reverting the sign of the negative aspartate 341 to a p sitive arginine 
(D341R) produces a transporter which is still functional but shows 
reduced transport currents and no reversal in the explored voltage 











































































currents at -140 mV were: 568 ± 58 nA for wild-type, 998 ± 172 nA 
for R282D, 464 ± 94 nA for R282A and 184 ± 35 for D341R (mean ± 
SE, n = 4 – 7). 
Another evident feature in the traces of the transport currents 
generated by the R282D and R282A mutants is the slow decline 
during the voltage pulse (arrows in Fig.3.17 A), a behaviour that may 
suggest either the existence of a deactivating process, or a progressive 
reduction in the driving force. 
In both R282D and R282A mutants the reversal potential of 
the transport current is shifted by changes in either the proton 
concentration or the substrate concentration (Fig.3.18). This result 
suggests that the translocation of the two species occurs in a coupled 
fashion. The shifts in Erev caused by the pH and substrate changes in 
the mutants R282D and R282A are plotted in Fig. 3.18 B and D. The 
slopes of the Erev vs. pH curve are -42.3 and -43.7 mV/pH unit 
respectively; although less than the 58 mV/pH unit predicted for a 
pure H+ current on the basis of the Nernst equation, these values are 
nevertheless consistent with a substantial contribution of H+ to the 
current. Similarly, the semilog plots of Erev vs [Gly-Gln] are not linear 
for both mutants (Fig.3.18 D) with even lower slopes compared to the 
pH dependence. The slope conductance (gslope) of the I/V curves at Erev 
has been also estimated. This parameter is plotted in Fig.3.18 as a 
function of pH and substrate concentration for both mutants. 
Interestingly, while gslope increases with increasing concentrations of 
Gly-Gln (Fig.3.18 D), it appears to be substantially independent from 
the proton concentration (Fig.3.18 B). This last reult is contrary to the 





an increase in slope conductance when the concentratio  of the 
permeating species is raised (Hille, 2001). 
 
Fig.3.18 Effects of changing pH and substrate  concentration on the R282D 
and R282A mutants. A: External alkalinization at fixed (1 mM) Gly-Gln 
concentration shifts the I/V curves towards more negative potentials. The 
change in Erev with pH is shown in B for R282D and for R282A. C: Positive 
shifts in the I/V curves produced by increasing the external Gly-Gln 
concentration at fixed pH (7.5) in the two mutants. The shifts in Erev induced 
in this case are plotted in D, together with the slope conductance at Erev; this 
parameter shows an increase at higher Gly-Gln concentrations. 
3.3.2 Current reversal in the wild-type and R282 
mutants 
The apparently anomalous effects mentioned above on the 
slope conductance around Erev, prompted us to perform other 
experiments aimed at better understanding this phenom on, both in 
the wild-type and in the R282D/A mutants. The necessity of further 























































































































































































controls was also suggested by the declining behaviour seen in the 
current traces in Fig.3.17. Long-lasting voltage- and current-clamp 
experiments have been performed on both wild-type and R282D 
mutant to investigate this point. Fig.3.19 A shows voltage-clamp 
experiments in which the membrane voltage was stepped twice from -
40 mV to +40 mV and back: the first step was given in the absence of 
substrate, and the second in presence of Gly-Gln 1 mM at pH 8. In 
these conditions, Erev should be close to -30 mV in the R282D mutant. 
 
Fig.3.19 A: Long lasting records showing the slow deactivation process 
following step voltage changes in R282D and WT PepT1: during the first 
seconds after the jump at +40 mV the current in the presence of substrate is 
more positive than in its absence (gray arrow); however, at later times it 
becomes more negative; B:Current clamp recordings at  pH 8 in R282D 
and WT PepT1: the addition of substrate induced depolarizations, implying 














































Fig.3.19 Aa shows that jumping to +40 mV when the 
transporter is activated by 1 mM Gly-Gln causes an instantaneous 
large outward current (black arrow) that declines with time constants 
in the order of fractions of seconds, and it is not seen in absence of the 
substrate (gray arrow). Initially the current is more positive than the 
value recorded at the same voltage in absence of substrate (dashed 
line), but at the end of the 20 s period at +40 mV it becomes less 
positive (that is, a negative current after subtraction). A qualitatively 
similar behaviour, although with smaller currents, was observed in the 
wild-type PepT1 (Fig.3.19 Ab). 
Fig.3.19 B shows complementary experiments performed 
again on both wild-type and R282D with analogous reults. The 
oocytes were kept in current-clamp conditions, i.e.an appropriate 
current was injected to keep the membrane voltage at a desired value 
before substrate application, but the membrane potential was let free 
to change as a consequence of transporter operation. The 
representative traces in Fig.3.19 Ba, from an oocyte expressing 
R282D, and in Fig.3.19 Bb, from an oocyte expressing wild-type 
PepT1, show that addition of 1 mM Gly-Gln at pH 8 (black bars) 
always induces a depolarization, irrespective of the starting value of 
the voltage (-40, 0 and +40 mV), indicating that the current generated 
by the transporter is in all cases in the inward diect on. 
3.3.3 The outward current is due to temporary 
accumulation of substrates 
To discriminate whether the current decays seen in Figs 3.17 





transporter-intrinsic deactivation process, a serie of experiments 
employing different strategies was performed. Fig.3.20 illustrates the 
results of a representative experiment using a protocol in which three 
fast (200 ms) voltage ramps ranging from +40 to -100 mV (or from -
140 to +40 mV) were superimposed to a long lasting voltage step to 
+40 (or -140) mV in conditions inducing the decay of the transport 
current in both directions (pH 8, 1 mM Gly-Gln). 
 
Fig.3.20 Step and ramps protocols to investigate the basis of the transport 
current decline. Ab and Bb show the subtracted (substrate minus control) 
transport currents: both records show the slowly declining currents, which 
are in the outward direction in Ab and in the inward direction in Bb. Ac and 
Bc: I/V relationships; in Ac the reversal potential moves toward more 
positive values with the second and third ramp, whereas in Bc the opposite 





















































As shown in Fig.3.20. Ac and Bc, the I/V curves derived from 
the ramps shift along the voltage axis according to the application 
order and to the level of the long-lasting voltage pulse. The ramps 
superimposed to the depolarizing (+40 mV) pulse exhibit a 
progressive shift toward more positive potentials (Fig.3.20 Ac), while 
those applied during the pulse to -140 mV are moved with time 
toward more negative potentials (Fig.3.20 Bc). Interestingly, in both 
cases the curves remain parallel to each other, so that it may be 
concluded that only the reversal potential is affected, not the 
conductance. 
These observations represent a strong indication that e 
decline of the transport current during either the depolarizing or the 
hyperpolarizing pulses is due to substrate concentration changes in the 
vicinity of the transporters. In fact, assuming that Erev might be written 









   
where TC stands for transported complex, the continuous 
inward flow during the hyperpolarizing pulse will increase [TC]in 
(and/or decrease [TC]out) causing Erev to change with time to more 
negative values, as observed in Fig.3.20 Bc. On the contrary, the 
initial outward current seen when stepping the potential from –60 to 
+40 mV (Fig.3.20 Ab) will decrease [TC]in (and/or increase [TC]out) 
shifting Erev to more positive potentials (Fig.3.20 Ac). 
On the whole, the results shown in Fig.3.20 indicate that the 
outward current seen during short depolarizations is caused by a local 






membrane and/or a local depletion of the complex at the extracellular 
side during the continuous inward transport occurring at the negative 
holding potential, confirming earlier suggestions (Kottra and Daniel, 
2001). 
In another series of experiments a prepulse lasting 2 s to +40 
mV from Vh = -40 mV was applied to the membrane before moving 
the potential to variable 1 s long test pulses (+40 to -140 mV). 
Fig.3.21 shows this kind of protocol applied to an oocyte expressing 
the R282D mutant at pH 7.5. Upon addition of 3 mM Gly- ln a 
slowly declining outward current is seen during the pr pulse, while an 
opposite behaviour (i.e. a slowly declining inward current) is observed 
at the most negative test pulse potentials (Fig.3.21 A middle traces). 
Subtraction of  the currents in the absence from those in the presence 
of substrate gives the isolated transport currents (Fig.3.21 A rightmost 
traces), in which the declining behaviour at negative potentials during 
the test pulses is still visible. The average I/V relationship obtained 
from the currents values at the end of the test pulses is plotted in 
Fig.3.21 C (open squares). It can be seen that using th s protocol no 
outward current can be observed up to +40 mV. In cotrast, a clear 
current reversal around +10 mV is noticeable in the same conditions 
of pH and Gly-Gln concentration when using the short depolarizing 
pulses from Vh = -60 mV (filled squares in Fig.3.21 C). 
This experiment indicates that during the prepulse to +40 mV 







Fig.3.21 Currents elicited by the prepulse protocol shown in B, in the absence  
and in the presence  of 3 mM GlyGln at pH 7.5 in an oocyte expressing the 
R282D isoform; C: Plot of the current at the end of the test pulse in Ac (open 
symbols); for comparison, the filled symbols are th data obtained using the 
short-duration pulse protocol (from Vh -60 mV) from another oocyte in the 
same conditions. 
 
To check the physiological relevance of this phenomenon, a 
similar approach was applied to oocytes expressing the wild-type form 
of PepT1. In this case a shorter (250 ms) prepulse to +40 mV was 
sufficient to abolish the temporary phase of outward current 
(Fig.3.22). The transport-associated currents, obtained as usual by 
subtracting the traces in the absence from those in the presence of 
substrate, were always inwardly directed, even in co ditions of 
alkaline pH and low organic substrate concentrations (Fig.3.22 A 






































rightmost traces). This correction, although modest, allows an 
extension of the voltage range in which the values of apparent affinity 
(1/K05) and maximal current (Imax) can be obtained from a Michaelis-
Menten analysis. 
 
Fig.3.22 Transport currents with the prepulse protocol. In the wild-type 
PepT1 a 250 ms prepulse duration was sufficient to abolish any outward 
current elicited by the jump from the -60 mV holding potential to positive 
potentials. This is demonstrated by the fact that the subtracted urrents (A, 
rightmost traces) are all in the inward direction; C, D: Imax and K05 obtained 
by Michaelis-Menten analysis on dose-current curves; open circles: same 
parameters calculated with the usual protocol. 
 
  The average values of K05 and Imax calculated from a group of 
oocytes tested with such protocol at pH 7.5 is shown in Fig.3.22 C and 
D (open squares), together with their counterpart obtained using the 
customary pulse protocol in which the test pulses were applied 






























































directly from Vh = -60 mV without prepulse (open circles). It can be 
seen that while the data from the classical protocol are limited to -40 
mV, because at more positive potentials the current at low substrate 
concentration becomes outwardly directed, the prepuls  protocol 
allows an extension of the analysis up to +20 mV, although for K05 the 
statistical error becomes very large also in this case. 
3.3.4 Intracellular injection of substrates 
In order to find further support to the results reported above, a 
series of experiments has been performed injecting substrates in the 
cytoplasm of the oocyte. This procedure was already reported to 
produce significant outward transport currents in wild-type PepT1, 
when using hydrolysis-resistant dipeptides, or inhibiting intracellular 
peptidases (Kottra et al., 2009). The results of our experiments on the 
wild-type and R282D, R282A and D341R isoforms are illustrated in 
Fig.3.23. In the upper part of this figure membrane voltage recordings 
in current-clamp condition are shown: first of all it can be noted that 
in all isoforms the resting membrane potential becomes significantly 
more negative after substrate injection (range -75 to -100 mV), 
compared to the initial -20 to -50 mV. This progressive 
hyperpolarization, already observed in the wild-type (Kottra et al., 
2009), develops in few minutes after injection and it is not observed in 
oocytes not expressing the transporters. The development of a strongly 
negative resting potential is clearly consistent with the activation of an 
outward current by the transporter as a consequence of the increased 






Fig.3.23  Application of Irbesartan. 
Top row: current-clamp recordings showing the resting potential 
changes induced by application of Irbesartan (IS) and Gly-Sar. 
Bottom graphs: corresponding uncorrected I/V relationships before 
(open symbols) and after (filled symbols) the injection of Gly-Sar. 
Squares are data in the absence and circles in the presence of IS. 
 
Additional evidence is provided by the application f the 
blocker Irbesartan (IS) (Knütter et al., 2009): the traces in Fig.3.23 
show that while external Gly-Sar 3 mM depolarizes the membrane 
when applied either before or after the intracellular injection, the 
application of Irbesartan (2 mM) is effective in producing a 
depolarization only after substrate injection. These last observations 
indicate that, while the depolarizations induced by external Gly-Sar 






































































































induced by Irbesartan are due to the inhibition of an outward current. 
Interestingly, the hyperpolarization of the resting membrane potential 
and the Irbesartan-induced depolarization are seen in all isoforms, 
including D341R, in spite of the much lower currents generated by 
this mutant. The I/V curves in Fig.3.23 confirm then the findings 
reported in the preceding figures, by showing the presence of a strong 
outward current following the intracellular injection of Gly-Sar, and a 
reduction of this current by Irbesartan. 
3.3.5 Ion and substrate specificity 
Previous results (Kulkarni et al., 2007;Pieri et al., 2008) 
(Meredith, 2004) have suggested that residues R282 and D341 form 
an ion bridge whose cyclic breaking and formation may gate the 
translocation process. Furthermore, it has been proposed (Meredith, 
2009) that PepT1 may represent a transitional entity between 
transporters and channels. Then possible alterations in ion and 
substrate specificity in the R282D mutant have been investigated (the 
same results were obtained in R282A as well). The possible 
participation of other cations in the current elicited by the organic 
substrate was tested by replacing external Na+ with K+, Li+ or 
tetramethylammonium ion (TMA+). However these ionic substitutions 
did not significantly alter the shape of the I/V relationships in the 
presence of Gly-Gln at various concentrations and pH values, as 
shown in Fig.3.24 for pH 8 and Gly-Gln 1 mM. It can be seen that the 
reversal potential and the outwardly directed current are independent 







Fig.3.24 Replacement of Na+ with TMA+ or K+ in the external solution did 
not alter significantly the amplitude or the reversal potential of the transport 
current elicited by the organic substrate. 
 
This result, together with the observations of Fig.3.18 confirms 
therefore that the species carrying the electrical charge in both 
directions are indeed protons in complex with the organic substrate. 
The substrate selectivity of R282D was also compared with 
that of the wild-type with special attention to the ability to generate 
reverse current. A first series of results is exemplified in Fig.3.25, 
where the capacity to transport di-, tri-, tetrapeptides, as well as 
histidine by the R282D mutant was tested. It is know  (Herrera-Ruiz 
and Knipp, 2003;Daniel et al., 2006) that PepT1 family members are 
able to transport several di- and tri-peptides, but not tetrapeptides. 
Furthermore, among the SLC15A family of transporters, the PepT 
subfamily is differentiated from the PHT subfamily  by its inability to 
transport histidine. The representative records of Fig.3.25 A show 
that, with respect to substrate selectivity, R282D behaves in a manner 
similar to the wild-type transporters. The same potency order was 
found in the other two tested mutants, R282A and D341R (not 
shown). Furthermore, as illustrated in Fig.3.25 B, tripeptides (LGG) 



































are also able to generate outward current when the short pulse 
protocol from Vh = -60 mV is used. 
 
Fig.3.25 Transport current elicited by di-, tri-, tetrapeptides and histidine in 
the wild-type and in the R282D mutant (GQ: gly-gln; GGGG: tetra glycine; 
GGG: tri glycine; LGG: leu-gly-gly; His: histidine). 
3.3.6 Charged dipeptides 
In the context of the substrate selectivity analysis, it seemed 
particularly interesting to examine the behaviour of the mutants in the 
charge-pair residues when charged dipeptides were used in place of 
the neutral substrates employed in all previous experiments. 
The relevance of introducing a negative or a positive amino 
acid in the substrate dipeptide, as well as its position was already 
studied in the wild-type PepT1 (Amasheh t al., 1997) (Kottra et al., 
2002). An important conclusion from these studies was that the 
binding pocket of PepT1 can accept only neutral amino acids at the 

























































Fig.3.26 Current-voltage relationships of the transport currents elicited by 
differently charged dipeptides in comparison with Gly- ln (all at 1 mM) in 
the indicated isoforms at pH 7.5. 
 
Fig.3.26 compares the transport currents generated at the same 
pH (7.5) and substrate concentration (1 mM) when a positive or a 
negative residue is introduced in either position of the dipeptide. The 
transport currents were normalized to the current generated by the 
neutral dipeptide Gly-Gln at -140 mV in each oocyte b fore 
averaging. The previous observations on the wild-type are 
qualitatively confirmed in the mutants: the transport currents 
generated by Lys-Gly are larger compared to Gly-Gln in all isoforms, 
while those produced by Gly-Lys and by the two negatively charged 
dipeptides are smaller. However, the degree of reduction or increase is 
different in the two mutants: in the R282D the differences are 
enhanced Lys-Gly showing a much larger increase (150% vs 60% in 
the wild type), while the currents generated by Gly-Lys, Gly-Asp and 
Asp-Gly are reduced relatively more than in the wild type. In the 
D341R form, that produces in general smaller currents (see Fig.3.17), 
the Gly-Lys, Gly-Asp and Asp-Gly currents are less strongly reduced, 
and the Lys-Gly current increases similarly to the wild-type. 


















































































Furthermore, Lys-Gly can produce large outward currents in R282D, 
while all substrates produce strongly inward-rectifying currents in 
D341R. 
The results for the wild-type are in line with previous 
observations (Amasheh et al., 1997) (Kottra et al., 2002), and 
qualitatively reflect the excess positive or negative charge of the 
different dipeptides at pH 7.5. The more than doubled slope of the I/V 
curves in the R282D mutant can be best explained with a nearly 
doubled charge/mole ratio and, in addition, with an increased turnover 
rate of the transporter. 
On the contrary, the lack of effect in the substrate selectivity 
order suggests that these mutations do not interfere with the binding 
pocket of the transporter. This prediction has been t sted by 
evaluating the amount of presteady-state charge move ent removed 
by interaction with the various dipeptides. It is known that in many 
transporters, including PepT1 (Sala-Rabanal et al., 2006;Sangaletti et 
al., 2009) the presteady-state currents in absence of substrate are 
mutually exclusive with the transport currents (i.e, they are 
progressively reduced with corresponding increases in transport 
current). Fig. 3.27 shows the residual charge movement in presence of 
1 mM of different dipeptides (Gly-Gln, Lys-Gly and Gly-Asp) in 
representative oocytes expressing the wild-type andthe mutants 






Fig. 3.27 Residual charge movement for the wild-type and the R282D and 
D341R mutants in the presence of a neutral, a basic and an acidic dipeptid  
as indicated (all at concentration 1 mM and pH 7.5). 
 
As shown in the traces of Fig. 3.27, 1 mM Gly-Gln and Lys-Gly 
remove almost completely the presteady-state currents in the wild 
type, while most of this kind of current remains in presence of the 
same amount of Gly-Asp (the same result was observed with Asp-Gly 
and Gly-Lys). These observations may be quantified comparing the 
Q/V curves obtained by integrating the presteady-state current isolated 
using a double exponential fitting of the traces in absence of substrate 
(considered to represent the total charge), to the int grals of the 
transient currents obtained by difference of the traces in absence and 
in presence of substrate (residual charge) (Fesce t al., 2002). These 
























































data are shown in the bottom graphs of Fig. 3.27. Clearly the residual 
charge in the presence of 1 mM Gly-Gln and Lys-Gly is close to zero 
in the wild type, and for these substrates it remains  small fraction of 
the total charge in both mutants. In contrast, for Gly-Asp the residual 
charge is close to the total charge in all isoforms. Analogous results 
were obtained for the other, poorly functional dipeptides (not shown). 
The amount of residual charge can be considered an estimate 
of the fraction of transporters not involved in the actual transport, i.e. 
transporters that do not interact with the substrate. In this view, the 
data of Fig. 3.27 indicate that for all isoforms Gly-Asp interacts 
poorly, while Gly-Gln and Lys-Gly show a comparable d gree of 
interaction between each other, although in the mutants this level 
appears lower than in the wild type. 
Taking together the results of Figs 3.26 and 3.27, it can be 
concluded that, since the level of interaction of Gly- ln and Lys-Gly 
with the R282D mutant is similar, the more than twofold increase in 
transport current by Lys-Gly should be ascribed to the increased 
charge/mole ratio of the transported complex, and possibly to an 





Chapter 4. Discussion 
4.1 Unified modeling of PepT1 
Electrophysiological results on the transport activity of PepT1 
have shown differences in the various species, ranging from an 
acidity-induced increase in Imax to no change or a decrease in seabass, 
zebrafish, and rabbit isoforms. More consistent effects are seen in the 
apparent affinity for substrate, which appears to increase with 
acidification in all cases. Although an increase in transport-associated 
current with lower pH is easily understood as a consequence of a 
stronger protonic electrochemical gradient, an increase in current at 
higher pH is harder to explain. The presteady-state currents of many 
ion-coupled transporters in the absence of organic substrate arise from 
the ion–transporter interaction and are qualitatively and quantitatively 
related to transport activity (Peres t al., 2004;Cherubino et al., 2010). 
Therefore, the properties of such currents in three isoforms showing 
partially different pH dependency have been analyzed in parallel, with 
the aim of gathering additional information to explain the observed 
differences. 
4.1.1 Comparison of the presteady-state currents in 
the different species 
An analysis of the presteady-state currents with respect to the 
voltage dependence of the decay time constant and the amount of 





differently (at the same external pH) on the voltage axis. The rabbit 
curves are positively shifted and the zebrafish curves are negatively 
shifted, with the seabass curves located close to the zebrafish ones. In 
addition, the decline in the presteady-state current following voltage 
jumps is faster in the zebrafish and seabass transporters than in the 
rabbit isoform. These results are in good agreement with the different 
isoelectric points of the three proteins: 7.47, 6.68, and 6.00 for rabbit, 
seabass, and zebrafish, respectively ((Daniel et al., 2006) and our 
calculation). This suggests that rabbit PepT1 may be protonated more 
easily than the fish isoforms. If this protonation includes the residues 
involved in establishing states T2 and T7 in our model, it may explain 
the slower rates of charge movement observed at the same pH in the 
rabbit protein.  
4.1.2 Effect of external pH on unidirectional rates  
As previously reported for the rabbit and seabass transporters 
(Nussberger et al., 1997;Sangaletti et al., 2009), the charge movement 
characteristics of all three proteins are affected by external pH through 
shifts along the voltage axis and an acceleration of the decay at 
alkaline pH. The analysis has been extended to calculate the 
unidirectional rate constants of charge movement in the membrane 
electrical field and their dependence on external pH. 
The results, shown in Fig.3.2, indicate that an increase in external 
protons slows down both inward and outward charge move ents in all 
of the examined species. These observations make it unlikely that the 
presteady-state currents are primarily caused by the movement of 





that the currents are mostly due to the rearrangement of intrinsic 
transporter charges. These results are in agreement with models 
proposed for rabbit (Nussberger t al., 1997) and for human PepT1 
(Irie et al., 2005), in which the presteady-state currents are generated 
largely by the movement of intrinsic transporter charges (negative, on 
the whole). In these models, inward and outward rates are slowed 
down by the binding of internal and external protons that trap the 
transporters in “occluded” states.  
Because these models do not account for the slowing down of the 
inward charge movement by external protons, a modification has been 
introducted by adding a new state (T7 of Fig.3.3) in which the “inward 
facing” transporter can bind external protons. Trapping of the 
transporter in state T7 by external protonation may then explain the 
decrease in inward rate of (positive) charge movement (transition T6 
→ T1) caused by acidic pH. The voltage- and pH-dependence of the 
unidirectional rates of charge movement was best fitted with a single 
conformational change of the intrinsically charged transporter over 
71% (rabbit) or 87% (fish) of the membrane electrical field. For this 
reason, a partial voltage dependence encompassing the residual 
fraction of the field was introduced in the transition between the 
outward- and inward-facing conformations of the fully loaded 
transporter (T3 ↔ T4). 
The ability of the model to reproduce the voltage dependence of 
the displaced charge and the decay time constant, as well as the effects 
of changing external pH, was verified by simulating the presteady-
state currents in the rabbit and a generalized fish PepT1 using kinetic 





Fig.3.4 show that the kinetic scheme of Fig.3.3 is capable of 
reproducing the properties of both the rabbit and fish PepT1 with only 
a minor adjustment of the parameters (Tab.3.2). 
4.1.3 Transport currents 
The model of Fig.3.3 was further tested to verify its ability to 
simulate the transport-associated currents. The comparison was 
limited to the currents generated by the neutral dipeptide Gly-Gln at 
pH 6.5 and 7.5, which should represent the physiolog cal conditions of 
the unstirred microenvironment in which PepT1 operates, at least in 
mammals (Thwaites and Anderson, 2007). Because the model was 
constructed from observations of the presteady-state currents and the 
parameters were optimized to simulate the characteristics of these 
currents, the behavior of the transport currents cannot be completely 
reproduced for two main reasons. First, different substrates may 
present specific interactions with the transporter that are difficult to 
incorporate in the model. Secondly, the model does not include the 
effects of the variable percentage of charged vs. uncharged species of 
substrate at different pH. In spite of these drawbacks, Fig.3.7 shows 
that simulations of mammalian and fish PepT1s using the additional 
parameters of Tab.3.3 can reproduce the basic experimental 
observations. There is less agreement than that obtained for the 
presteady-state currents, and it is mostly limited to qualitative aspects 
such as changes in the relative amplitudes of Imax at different pH 
values and the common higher affinity at the more acidic pH. The 
general trend of the voltage dependence of affinity is mimicked, 





As already mentioned, the pH dependence of the maxial 
transport current of human PepT1 is the opposite of that of rabbit and 
fish (Amasheh et al., 1997;Steel et al., 1997;Kottra and Daniel, 
2001;Verri et al., 2003;Sangaletti et al., 2009). In an analysis by 
Fujisawa and coworkers, the pH dependency of human PepT1 was 
bell-shaped, with maximal transport rate at pH 5.5. Although the 
decreasing transport at high pH values is caused by a reduced 
transmembrane pH gradient, the decrease at low pH results from a 
change in the transporter protein itself caused by  protonation of a 
histidine residue near the substrate binding domain (Fujisawa et al., 
2006). The model presented here similarly predicts that Imax should 
decrease at both extreme acidic and alkaline pH. Depending on the pH 
at which the maximal transport rate occurs and the width of the bell-
shaped Imax vs. pH curve (possibly related to slight structural 
differences in the functionally important regions), this feature can 
account for all observed species-specific differences in the pH 
dependencies, including the increase in Imax with acidity found in the 
human PepT1(Mackenzie t al., 1996). The observed differences in 
the pH dependencies may be related to the actual pH values found in 
the small intestine. Although slightly acidic values are found in 
mammals because there is no luminal expression of the sodium-proton 
exchanger (NHE3), the microenvironment of zebrafish enterocytes 
should be alkaline, thus allowing optimal conditions for peptide 
transport (Verri et al., 2003). Interestingly, the type-II Na+-phosphate 
cotransporter cloned from the zebrafish intestine also exhibits 






4.2 Electrostatic gates in PepT1 
Different researchers studied a number of mutants in PepT1 
residues R282 and D341, reporting various effects on the transport 
characteristics (Meredith, 2004;Kulkarni et al., 2007;Pieri et al., 
2008;Meredith, 2009). No informations however have be n published 
to date on the properties of the presteady-state currents generated by 
mutants in these residues. Then these currents have been investigated, 
trying also to correlate the observations regarding the initial steps of 
the transport cycle with those on the complete transport cycle. 
4.2.1 Effects of mutations on the presteady-state 
currents 
Single-residue mutations of arginine 282 in lysine, alanine, 
glutamine, glutamate or aspartate produce functional transporters 
displaying conspicuous presteady-state and transport currents. In 
contrast, both types of current are strongly reduce in the D341R 
mutant. Localization experiments show that all these isoforms are 
present in the oocyte membrane, with the mutants having in many 
cases significantly larger surface expression than e wild-type. While 
the correspondence between localization and functio is very good for 
the wild-type, and all the arginine mutants, the lack of correlation for 
the D341R form suggests that its reduced activity is not due to 
insufficient targeting but to defects in the molecular mechanism. The 
other two mutations tested, the double mutant R282D-D341R, aimed 
to reestablish the charge pair, and H57R, did not generate presteady 
nor steady transport currents. However, while the latter gave a strong 





the functional nature of the defect, the double mutant R282D-D341R 
was not detectable in the membrane (Fig.3.10), and co sequently no 
transporter-related currents were observed (Fig.3.9). 
Changes in external pH affected the characteristics of the 
presteady-state currents in all functional mutants (Fig.3.11). This 
observation indicates that mutations deep in the structure of the 
transporter do not alter the ability to interact wih protons even in the 
absence of organic substrate. 
The characteristics of the presteady-state currents are changed 
in opposite ways by the non-conservative mutations  the two 
different residues: both Q/V and τ/V curves are shifted to the right 
along the voltage axis in the R282D, R282E, R282Q and R282A 
forms, and to the left in the D341R form (Fig.3.12). Boltzmann 
analysis of the charge vs voltage curves reveals only small changes in 
the slope of the sigmoidal for the arginine mutants. This observation 
implies the constancy of the equivalent electrical distance δ, and 
therefore makes it unlikely that the mutated residues could be directly 
involved in the charge-moving conformational rearrangement. The 
decrease in δ resulting from the greater slope factor for D341R 
(Tab.3.4) may reflect a distortion in the protein structure in this 
mutant, or it may simply represent an overestimate du  to the lack of 
saturation of the Q/V curve in this mutant. However, forcing the slope 
parameter for D341R to the wild-type value (29.7 mV) in the 
Boltzmann analysis produced only negligible changes in the 
unidirectional rate constants. 
Derivation of the unidirectional rate constants of the charge 





is the inward rate of movement of a positive charge, or the outward 
rate of movement of a negative charge) is enhanced when the positive 
arginine 282 is neutralized to alanine or glutamine, or is replaced by a 
negative aspartate or glutamate; correspondingly the outward rate is 
diminished in these mutants with respect to the wild-type. The 
opposite effect occurs when the negative aspartate 341 is replaced by 
a positive arginine: in this case the outward rate is nhanced, while the 
inward rate is depressed. 
This behaviour appears consistent with the idea that residues 
R282 and D341 participate in the generation of a loc l electrical field 
over which the voltage-dependent charge movement in absence of 
substrate occurs (Fig.4.1). Although only the knowledge of the atomic 
structure will allow making accurate calculations, it is reasonable to 
think that neutralization of positive arginine or reversal of its charge 
will generate a negative local potential that will distort the 
intramembrane potential profile. Conversely, the substitution of a 
negative aspartate with a positive arginine will alter the potential 
profile in the opposite (positive) way (Fig.4.1 Ba). It may be 
speculated that in this last case the positive electrical field generated 
by the arginine residue might be so strong so that very little charge 
movement can occur in the experimentally useful voltage range, as 
observed experimentally. 
This explanation is analogous to that used to account for the 
shifting effects of divalent cations or ionic strength on voltage-






Fig.4.1 Schematic representation of the electrostatic fields generated by the 
pair R282-D341 and their mutations. 
Light red and blue areas represent negative and positive electrical fields, 
respectively. In the absence of substrate reversal of the positive field 
generated by R282, causes a negative distortion to the membrane potential 
profile, producing an increase in the field effectively acting on the charge 
movement (red line in Ba). The opposite mutation D341R adds a positive 
component to the membrane potential profile causing a decrease in the field 
effectively acting on the charge movement (blue line in Ba). To reach the 
same level of electrical field acting on the charge movement (yellow band) 
the  intracellular voltage (Vin) must compensate for these alterations and be 
set to +∆V or −∆V, respectively, for the two mutants (Bb). 
 
Referring to the potential profiles shown in Fig.4.1 Ba, the 
local potential increase caused by the extra arginine will reduce the 





therefore to obtain the same rate of charge movement as in the wild-
type (black profile line), the intracellular potential will have to be 
moved more negative by ∆V (Fig.4.1 Bb, blue line). Consequently the 
voltage dependence of the unidirectional rates will be shifted towards 
more negative potentials (Fig.4.1 Bc). The same arguments in the 
opposite direction can be used to explain the positive shift observed in 
the non-conservative R282 mutants (Fig.4.1 B). Considering the 
exponential nature of the curves, the voltage shift w ll appear as a 
change in amplitude at a fixed potential. 
The gradation of effects observed experimentally does not 
exactly correspond to what may be simplistically expected, i.e. that 
neutral substitutions (R282Q and R282A) should have less effect than 
charge reverting mutations (R282D and R282E). Indeed R282A 
appears to have effects lying midway between those of R282D and 
R282E, while those of R282Q are located between the wild-type and 
R282D. These observations suggest that the polar vs non-polar nature 
of the residues and steric factors may also be important in determining 
the rates of charge movement. 
4.2.2 Transport currents 
The amplitudes of the transport-associated currents generated 
by the addition of organic substrate are in good correlation with the 
amount of intramembrane charge movement in each isoform: while 
the non-conservative R282 mutants are able to generate t ansport 
currents comparable or even larger than the wild-type, D341R shows 
much reduced currents. 





transport-related currents are affected by changes in xternal pH and 
in the concentration of organic substrate. An increase in either one of 
these two factors cause larger currents and also shifts t e curves 
toward more positive potentials. This effect is particularly evident in 
the R282 mutants that exhibit a clear reversal of the current direction. 
In these mutants Erev shifts with the concentration of external protons 
with a slope between -38 and -49 mV/pH decade (depending on the 
isoform) that, although less than the value predict by the Nernst 
equation, indicates anyway an important role of protons as charge 
carriers. The change in Erev induced by different Gly-Gln 
concentration at constant pH, also observed in these mutants, can only 
be explained if the translocation of this neutral dipeptide occurs as a 
complex with an electrical charge, supporting the id a that protons 
bind to the carboxylic group of the substrate in the translocation 
process (Kulkarni et al., 2007;Pieri et al., 2008). 
The experiments on the transport currents confirm therefore 
that the mutants maintain the essential characteristics of a pH-
dependent cotransport system, coupling the translocation of protons 
and organic substrate, as in the wild-type.  
The change in direction of the transport current and shift in Erev 
with substrate concentration observed in the non-conservative arginine 
mutants make it difficult to estimate the apparent substrate affinity in 
the usual way, i.e. by fitting Michaelis –Menten equations to current 
vs concentration plots. To obtain an estimate of possible alterations in 
the substrate affinity in these mutants, the chord conductance of the 
I/V plots has been used (Fig.3.15) (Aidley, 1989). According to eq.3.8, 





positive, being divided by the electrochemical gradient (V – Erev). As 
shown in Fig.3.15, the estimate of the substrate concentration 
producing half the maximal conductance is, in the wild-type, similar 
to that calculated with the usual methods (our unpublished 
observations, and (Mackenzie et al., 1996;Kottra and Daniel, 2001)). 
The values of GK05  for the R282D mutants, calculated in the same 
way, show a reduction of about 50% of the apparent affinity compared 
to the wild-type.  
All functional mutants are able to transport charged dipeptides 
as well. The results shown in Fig.3.16 confirm previous observations 
(Amasheh et al., 1997;Kottra et al., 2002) concerning the wild-type 
that showed variable charge/molar ratios depending on the charge of 
the dipeptide and on the external pH. Therefore the small currents 
elicited by Asp-Gly (in contrast to the larger ones produced by Lys-
Gly) can be attributed to the high percentage of the side chains bearing 
a negative charge at this pH (7.5). The different shape of the I/V 
curves (rectifying vs linear) appears to be isoform-dependent (and 
substrate-independent), suggesting that the translocation mechanism is 
determined by the structure of the transporter, and not by the nature of 
the substrate. The relatively stronger increase (compared to the wild-
type) observed in the current generated by Lys-Gly in the non-
conservative arginine mutants, indicates that in addition to the greater 
charge/mole ratio an increase in turnover rate may h ve occurred, 
possibly due to a faster release rate of a more strongly charged 





4.2.3 R282 and D341 represent the gates of the 
transport cycle 
The idea that the transport cycle of PepT1 could be gat d by 
these two residues was put forward by Kulkarni et al. (Kulkarni et al., 
2007) who proposed a cyclic breaking and reconstitution of the ionic 
interaction. The electrophysiological characterization of the six 
functional mutants, described above, gives support to this hypothesis. 
The shifts along the voltage axis of the charge movement parameters 
shown in Fig.3.12 may be explained as due to alterations in the 
intramembrane electrical field caused by the differently charged 
mutants with a likely contributions of steric effects, as mentioned 
above (see for example the difference between the R282A and R282Q 
mutants). 
The different amplitude and voltage dependence of the
transport current in the mutants are also relevant in this respect. With 
the exception of the conservative R282K mutation, all other functional 
mutations disrupt the charge pair, however they do so in different 
ways. In the non-conservative arginine mutations an excess negative 
charge is produced: although the details of the local conformational 
rearrangement of the mutated protein are unknown, it is conceivable 
that the passage of positively charged substrates, such as the Gly-Gln-
H+ complex might be favoured in these cases (see Fig.4.1). 
As shown in the Results section, the symmetrical mutation on 
the other residue of the pair, that is D341R, showed much reduced 
presteady-state and transport currents. In contrast i s expression on the 
plasma membrane of the oocytes was comparable with the other fully 





Fig.4.1 suggests that in this case the presence of the positive charge of 
the arginine may produce an additional positive electrical field 
preventing protons to reach the appropriate site to form a complex 
with the substrate. 
The experiments using charged dipeptides confirmed the 
efficiency order observed for the wild-type transporter at pH 7.5 (Asp-
Gly < Gly-Gln < Lys-Gly) with only small relative variations in all 
tested mutants. This observation suggests that the mutations in the 
charge-pair residues affect mainly the proton interaction rather than 
substrate binding and translocation. 
4.3 Reverse operation in PepT1 
The PepT1 mutants investigated in the present work are 
correctly expressed in the oocyte membrane (Fig.3.17), and maintain 
the characteristic of true cotransporters, as it is shown by the fact that 
both protons and substrate concentrations affect th reversal potential 
of the transport current (Fig.3.18), and that the substrate selectivity is 
unaltered. Although qualitatively in the correct direction, the shifts in 
Erev significantly deviate from the predictions of the N rnst equation. 
Further difficulties arise when examining the slope conductance of the 
transport current at the reversal potential: according to the theory of 
electrodiffusion (Hille, 2001) this parameter should increase when the 
concentration of the diffusing species is increased. As shown in 
Fig.3.18 this is verified for the dipeptide substrate Gly-Gln, but not for 
protons, for which no significant dependency of gslope is found.  
Having established that R282D and R282A can be considered 





(conspicuous outward currents), the functional and structural 
determinants of reverse operation in these proteins have been 
investigated. 
4.3.1 Determinants of reverse operation in PepT1 
The experiments illustrated in Fig.3.19 show that te outward 
currents visible in Figs 3.17 and 3.18 are only temporary and may be 
consequent to the active state of the transporters at negative holding 
potentials. These declining outward currents might be considered 
similar to the “tail” currents observed in voltage-activated ionic 
channels when stepping the voltage from a condition in which the 
channel is open, to other voltages where it will close (Hodgkin and 
Huxley, 1952;Hille, 2001). If this is the case, the I/V curves obtained 
from relatively short (<1 s) pulses may actually represent 
“instantaneous” I/V relationships of the current generated by the 
transporter at the level of activation of the holding potential.  
The observation (Figs 3.17 and 3.20) that the transport current 
declines during strong voltage pulses in either depolarizing or 
hyperpolarizing directions suggests that this effect may arise from 
changes in the driving force, rather than from an intrinsic deactivation 
process of the transporter, because this last kind of process usually 
depends monotonically on voltage. The hypothesis of a reduction in 
driving force is demonstrated by the results of the experiments of Figs 
3.20, 3.21 and 3.22, as well as from the long-lasting recordings of 
Fig.3.19. In fact, during a prolonged flux of the proton-substrate 
complex a local accumulation and/or depletion of the complex may 





concentration-dependent component of the electrochemical gradient 
causing a current decline. 
The experiment of Fig.3.20 clearly demonstrates the 
occurrence of this phenomenon in both directions: i fact, during a 
long lasting hyperpolarization the reversal potential becomes 
progressively more negative in agreement with a decrease in the out/in 
ratio of the concentrations of the transported species [eq.3.9]. Vice 
versa, during a long lasting depolarization, the Erev shift is toward 
more positive potentials, consistent with an increase in the out/in  
concentration ratio. However the I/V relationships measured at 
different times during the long pulses in either diection remain 
parallel to each other, excluding changes in the intrinsic rate of 
transport. Although this effect is most evident in he two arginine 282 
mutants, it was shown that the hypothesis of a transport-dependent 
local concentration change can also explain the findings regarding the 
wild-type transporter (Kottra and Daniel, 2001). The experiments of 
Figs 3.21 and 3.22 show that using an appropriate protocol the 
accumulation/depletion effect can be reduced, and this leads to more 
accurate determinations of the kinetic properties of transport (Imax and 
K05), whose values can be obtained over an extended range of 
membrane potentials. The ability to conduct current in he outward 
direction was already demonstrated in the wild-type PepT1 (Kottra et 
al., 2009). It was shown here that not only mutants in arginine 282 but 
also D341R exhibit the same capacity in presence of high intracellular 
concentrations of a non-hydrolizable substrate. This finding indicates 
that the different shape of the I/V curves exhibited by the different  





obtained using a classical pulse protocol from Vh = - 60 mV is not 
related to an intrinsic incapacity of the wild-type and D341R forms to 
transport in reverse mode, but depends on the different transport rates, 
producing different degrees of accumulation/depletion effects. Indeed 
the transformation from linear to inward rectifying can be obtained 
using appropriate protocols (see Fig.3.21). 
4.3.2 Other substrates 
Of the two residues forming a putative charge-pair in the 
PepT1 structure, R282 and D341 (Kulkarni et al., 2007;Pieri et al., 
2008), only mutants in arginine 282 present the outward current 
phenotype (Fig.3.17). Our initial results using the n utral dipeptide 
Gly-Gln showed that the arginine mutants facilitate th  substrate flow 
both in terms of amplitude and direction, since the I/V relationships 
are approximately linear; while the symmetric mutation D341R has an 
opposite action, rendering more difficult the transport of substrates, 
and enhancing the inward rectification property alre dy present in the 
wild-type. 
The subsequent experiments in presence of different cations 
(Li+ , K+ and TMA+), and using various organic substrates, showed 
that the mutations do not introduce qualitative alter tion in ionic 
selectivity, nor in substrate specificity. Protons appear to remain the 
charge carriers, and the potency order of substrate of different size or 
bearing different charge is not changed compared to the wild-type. 
Furthermore, the reversal of the transport current ca  be also observed 
with tripeptides, suggesting that this property is not substrate-





The selectivity order of the charged dipeptides remains 
substantially unaltered in the mutants compared to the wild-type at pH 
7.5. The two negatively charged dipeptide produce only small 
currents, reflecting the high percentage of the side chains bearing a 
negative charge at this pH. The two positive dipeptid s highlight the 
relevance of the position of the charge: when the lysine is at the amino 
terminus the transporter is able to generate larger currents, while when 
it is located at the carboxy terminus the currents are much reduced 
(Kottra et al., 2002). Quantitatively, the behaviour of the charge-
reverting mutants R282D and D341R is opposite in many respect: 
while R282D shows increased current relative to the wild-type, the 
current generated by D341R is much reduced (see Fig.3.17). This 
observation is consistent with the idea of these two residues being part 
of the gate controlling the flux of inward positive charges: 
neutralization of the positive arginine 282, or its replacement with a 
negative amino acid, may facilitate the approach of the positively 
charged transport complex, while the replacement of he negative 
aspartate 341 with a positive arginine may have the opposite effect. 
This notion is also supported by the amplified increase (relative to 
Gly-Gln) in the current generated by Lys-Gly in the R282D mutant 
compared to wild-type and D341R. This effect is mirrored by the 
stronger reduction in the same mutant of the current generated by 
Asp-Gly, compared to the wild-type. Interestingly, this last substrate 
produces a higher fraction of the Gly-Gln current i the D341R 





Chapter 5. Conclusions 
In this work new determinants have been identified into function 
and structure of PepT1 because, in addition to its role in nutrient 
uptake, this transporter represents a major pathway for the absorption 
of several therapeutic drugs. 
First of all, a unified kinetic scheme has been proposed that 
explains the main electrophysiological properties of PepT1 in the 
presence and absence of organic substrate and its pH de endence. The 
model also can describe the behavior of different isoforms from 
mammalian and fish species. 
Interestingly, these results suggest a dual role for pr tons in the 
operation of PepT1. In the proposed model, protons are fundamental 
to neutralize the transporter during the inward substrate translocation, 
and their release in the cytosol uncovers the net negative charge of the 
empty transporter, which then undergoes an energy-dissipating 
working stroke to return to the outward-facing conformation 
(transition T6 → T1 in Fig.3.3). However, protonation of the 
transporter in another site breaks the transport cycle and counteracts 
the potentiating effects of external acidity on the turnover rate. As 
demonstrated by the proposed model, a different balance between the 
two roles played by protons may generate opposite effects on the 
maximal transport velocity, as has been experimentally observed in 
human PepT1 vs. rabbit or fish transporters. The exist nce of two 
apparently contrasting actions of external protons does not negatively 





and affinity are generally inversely related in transport processes 
(Soragna et al., 2005). Indeed, using the ratio of Imax to K05 as an index 
of the efficiency of transport, both experimental dta and our model 
showed that PepT1 is well optimized to meet its functio  across 
species and expected physiological pH conditions. 
Mutagenesis studies have shown that the oppositely charged 
residues Arg282 and Asp341, in the transmembrane domain 7 and 8 of 
PepT1, form a barrier in the absorption pathway. Substitution of 
Arg282 with neutral or negatively charged residues produce a shift 
towards more positive potentials in the characteristics of charge 
movement with respect to the wild-type form. Conversely replacement 
of Asp341 with Arg reduce both presteady-state and transport currents 
and produce a negative shift of the charge movement properties. In 
summary, residues R282 and D341 participate in the generation of a 
local electrical field over which the voltage-depend t charge 
movement in the absence of substrate occurs. Removal or reversal of 
the positive field generated by Arg282 cause a negative distortion to 
the membrane potential profile, producing an increase in the field 
strength effectively acting on the inward charge movement. To reach 
the same level of electrical field acting on the charge movement the 
intracellular voltage must compensate for this alter tion and be set to 
less negative values. In contrast, the mutation Asp341Arg adds a 
positive component to the membrane potential profile and must be 
compensate by an increased membrane negativity. Thus, t e shown 
results support the idea that Arg282 and Asp341 play the role of 





Finally, mutants in the putative charge pair residues Arg282 and 
Asp341 of rabbit PepT1 have been shown exhibit properties useful to 
better understand the possibility of reverse transport. In fact, wild-type 
and Arg282 mutants, while retaining the essential characteristics of 
proton-coupled cotransporters, exhibit outward currents in the 
presence of Gly-Gln. Long-lasting voltage- and current-clamp 
experiments have shown that these currents are only temporary, and 
reflect accumulation and/or depletion effects near the membrane. The 
reversal potential of the outward currents is affected by both pH and 
substrate concentration, confirming coupled transport in the wild-type 
and in the mutants as well. Removal of arginine 282 appears to 
facilitate the flow of the transported complex in both directions, while 
replacement of aspartate 341 with a positive residu limits the 
transport rate and strengthens the inwardly-rectifying characteristics 
of the wild-type transporter. This observation is consistent with the 
idea of these two residues being part of the gate controlling the flux of 
inward positive charges. 
This work has contributed to better understand the mode of 
transport by which PepT1 binds and transports its substrates that it’s 
of great interest to researchers; moreover these detailed functional 
information can be also used to make PepT1 a good drug elivery 
system. 
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